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INTRODUCTION 
Newcastle disease virus has been studied by research workers through­
out the world since it was first isolated in 1926. Much of the early work 
was directed toward field and laboratory diagnostic procedures and methods 
of immunization because of the economic importance of the disease to the 
poultry industry. With new and improved virus techniques, more detailed 
quantitative and qualitative studies of the virus particles were possible, 
and an immense amount of knowledge has been acquired regarding the 
characteristics of the numerous strains of the virus. 
Newcastle disease virus has many assayable properties that are 
affected by physical stresses. This makes the virus a useful tool for 
the study of the stress of properties considered to be related to 
structure. 
Tissue culture techniques have the distinct advantage over other 
methods of propagation of viruses for study in that theoretically it is 
possible through the harvest of single plaques to produce a homogeneous 
population from a single virus particle. 
The ability of a virus to withstand physical stresses can be 
hypothesized as being either related to the structural stability of the 
specific unit being measured or to the structural stability of some other 
aspect of the virus which affects the property being measured. Compara­
tive stress studies of several virus strains differing markedly in some 
property related to structure could give insight into whether stability 
differences are related directly or indirectly to the specific property 
being measured. 
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REVIEW OF LITERATURE 
Newcastle disease virus was first isolated by Doyle in 1926 (40) 
from poultry sick with a respiratory disease. The disease spread rapidly 
and resulted in a high mortality among the birds affected. He named the 
condition Newcastle disease because the first outbreak identified by him 
had occurred at Newcastle, England. This virus disease finally proved to 
be identical to the disease of fowls which had been described as 
occurring in the Dutch East Indies in 1926 (11). During the next several 
years investigators in several other counties (11, 27, 110, 117) 
described similar poultry diseases under a variety of names, but when the 
etiological agents were isolated and studied it was found that they were 
antigenically related to the virus of Newcastle disease (7, 11, 51). 
Since the disease was first described, the Newcastle disease virus has 
been isolated from gallinaceous birds (8, 9, 10, 13) and certain species 
of mammals (17, 137), including man (76, 107, 108, 136). 
The possibility that more than one strain of Newcastle disease virus 
existed was first suggested when great differences were noted in the 
severity of the clinical signs and the mortality rate among the flocks 
affected with Newcastle disease in various parts of the world. Following 
the first reports from England, a very mild or subclinical form of the 
disease was also reported (17). In addition, Newcastle disease virus 
resulted in a highly variable death rate among the flocks in the United 
States, varying from a low of 10 percent to a high of 90 percent (55, 
128). 
Farinas and others (51, 63, 71, 118) demonstrated that the Newcastle 
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disease virus might occur in any or all of the following tissues of fowls 
affected with Newcastle disease: spleen, kidneys, ovaries, testes, liver, 
lungs and brain. The virus was referred to as a neurotropic virus 
because of nervous symptoms observed in some of the affected birds (120). 
It was later found that a great variation existed among the strains in 
their affinity for nervous tissue (17, 18). The differences in 
tropisims of the virus was demonstrated by Jungherr (79) as a cause for 
the variations in range of invasiveness, symptoms, lesions and the course 
of the disease. Kohn (85) demonstrated the importance of the route of 
infection and the part this played in the susceptibility of chicks. 
Hitchner et al. (70) demonstrated the difference in pathogenicity of 
various strains for chicken embryos as well as for baby chicks. 
Newcastle disease virus is frequently grouped as lentogenic, meso-
genic and velogenic (63). Strains of the lentogenic group require 100 
hours or more to kill chick embryos and do not multiply in the nervous 
tissue of chickens. The mesogenic group kills embryos more rapidly (at 
about 60 hours). When mesogenic strains are introduced by the intra­
cerebral route, they will multiply in nervous tissues of chickens but 
will seldom kill adult birds when challenged by other routes. The velo­
genic strains of the virus produce severe clinical signs and high death 
loss in chickens and kill chicken embryos in 50 hours or less. 
Different Newcastle disease virus strains resulted in a variety of 
gross lesions as described by Jungherr et al. (79). The gross lesions 
varied greatly at necropsy of chickens sickened with acute, subacute and 
chronic Newcastle disease with some birds showing no observable 
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pathological changes. Hemorrhages of the mucosa of the proventriculus, 
and at times the gizzard, were more prominent and in a higher percent of 
the birds infected with the European strains than with several of the 
American strains. The European strains usually produce a hemorrhagic 
necrosis of the lymphoid patches and follicles of the intestine. Beach 
(7) reported that the California strains of high virulence also produced 
intestinal lesions. 
Antibody production was noted in the early studies with Newcastle 
disease virus. Doyle (40) and Farinas (51) used cross immunity tests to 
prove the relationship among the etiological agents isolated from poultry 
affected with similar symptoms. Beach (7) conducted neutralization 
studies to demonstrate the antigenic relationship among the viruses 
isolated from poultry sickening from the respiratory diseases occurring 
in the United States and Newcastle disease virus. Keogh (81, 82) noted 
that embryos were not infected with virus which had been neutralized with 
specific antiserum. Upton et al. (127) noted differences in virus 
strains by using 17 heterologous combinations of the virus and antiserum 
in the serum neutralization test. The antigen-antibody reactions for 
Newcastle disease virus were demonstrated and found to be highly specific 
by using the direct and indirect complement-fixation serological test but 
lacked a high degree of strain specificity (14, 19). 
In 1942, Burnet (21, 66, 98) demonstrated the ability of Newcastle 
disease virus to cause hemagglutination of chicken red blood cells in 
much the same manner as the hemagglutination produced by the influenza 
virus. 
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Newcastle disease virus does not cause hemagglutination of the red 
blood cells of all species, nor do all strains of the virus clump the red 
blood cells of individuals of the same species equally well (4, 33, 43, 
67, 95, 132). The sites on the virus which allow the attachment of the 
virus to the red blood cells in hemagglutination are thought to be 
similar to the sites of attachment of the virus and host cells in the 
infective process (111). It has also been noted that the hemagglutina­
tion activity of the virus and the virus concentration of the infected 
chicken embryo vary with the virus strains, route of inoculation, and in 
the various tissues and fluids of the embryo (72, 96). 
Newcastle disease virus is grouped with the myxoviruses, all con­
taining an enzyme which is capable of removing neuraminic acid 
derivatives from some cormaon mucoproteins (1, 68). Other viruses of the 
group are the fowl plague, influenza A, B, C, and D and mumps. 
The myxoviruses elute spontaneously after adsorption to the red 
blood cells (68, 113, 114, 115). The red cells lose their virus receptor 
sites involved in the attachment during release of the virus and finally 
are not capable of further virus adsorption by the same virus. The 
eluted virus can be adsorbed and released many times without detectable 
change in virus properties. Two differences of thought exist concerning 
the virus-red blood cell combination. Some consider adsorption as a 
function of all the virus surface while others regard the union as a 
function of the virus enzyme and the substrate of the red blood cell (58). 
The elution occurs because of the virus enzyme altering the receptor of 
the red blood cell. The elution property varies greatly with the 
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different strains of Newcastle disease virus (32). 
The hemagglutination-inhibition of Newcastle disease virus by the 
specific immune serum was demonstrated by Burnet (21) and Lush (96). The 
mechanism of hemagglutination-inhibition reaction appeared to be the same 
as that of neutralization of the virus (112). Doll et al. (39) in study­
ing the factors influencing the degree of hemagglutination-inhibition of 
Newcastle disease virus by the anciô^rum decided that the response 
varied with the strain of virus used, route of inoculation of the virus 
for production of the antiserum and the length of time allowed for anti­
body response. 
The hemolytic activity associated with the action of Newcastle 
disease virus on red blood cells was described by Kilham in 1949 (83). 
Burnet (22, 23) and Burnet and Lind (26) further characterized the virus 
hemolytic property the following year. McCollum et al. (99) pointed out 
in their studies that the hemolytic activity varied with the different 
strains of the virus. Newcastle disease virus antiserum will neutralize 
the virus and prevent the laking of the red blood cells. It was further 
noted that the virus varied in the ability to produce hemolysis in vari­
ous species of red blood cells (31). It was not as active for human and 
sheep red blood cells as for the fowl red blood cells. 
Farinas (51) first demonstrated the unfavorable effect of tempera­
tures above 40°-43°C on Newcastle disease virus. Using several strains 
of the virus, Bushnell and Erwin (28) found the thermal death point of 
the virus in allanto-ammiotic fluids to be between 58° and 64°C after 30 
minutes of exposure. The thermostability studies on various strains of 
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Newcastle disease virus with widely varying virulence demonstrated that 
the ability of the virus to survive outside the body of the animal was 
related to the original quantity of the virus instead of the virulence 
(2, 15, 54, 62). Using 31 strains of the virus, all were infective after 
15 minutes exposure at 56°C, three were non-infective after 30 minutes 
and the infective property of three of the strains was not destroyed 
after three hours at this temperature (16). Mutants, obtained from the 
Najarian strain of Newcastle disease virus, were infective for chicken 
embryos after exposure to 56°G for four times as long as the parent 
survived the temperature (56). 
The hemagglutinating property of Newcastle disease virus also varies 
greatly in thermostability. The hemagglutinins of different strains were 
destroyed at 56°C in from five minutes to six hours (64). Hofstad and 
Picken^ demonstrated that hemagglutination heat sensitive and hemaggluti­
nation heat resistant substrains could be derived from four of the five 
laboratory Newcastle disease virus strains examined. The hemagglutinin 
was destroyed in less than 10 minutes at 56°C in the heat sensitive sub­
strains but remained active in the resistant substrains after heating at 
56°C for 60 minutes. 
McCollum and Brandly (99) used three strains of the virus in study­
ing the effect of 56°C heat on the hemolytic property. Two of the strains 
failed to produce hemolysis after five minutes at 56°C and after 10 
minutes the third strain did not cause lysis of the red blood cells. 
•'•Hofstad, M. S. and Picken, J. C., Jr., Ames, Iowa. A comparison of 
the effect of heat and ionizing radiation on viability and hemaggluti-
nating properties of several strains of Newcastle disease virus. Private 
communication. 1961. 
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From filtration studies, the size of Newcastle disease virus was 
found to be between 80-120 m[i in diameter (25, 120). By using electron 
microscope techniques the size of an elementary body was determined to 
be approximately 115 mg in diameter and to have a molecular weight of 
450 million (3, 5). A light scattering technique used by Oster (105) 
also showed the virus size to be 115 m|i. These findings compared 
favorably with those determined by centrifugation. 
The Newcastle disease virus particle has been described as having 
both spherical and filamentous forms. Bang (3) described the sperm-
shaped particles as morphological artifacts based on observations 
following the changes in shape of the virus by action of hypertonic and 
physiological salt solutions. Kilham et al. (84) listed the filamen­
tous forms as having a width of 90 mji and lengths from 270 to 980 mji. 
Wilson and Pollard (131) using irradiation procedures for measuring 
the size of Newcastle disease virus accumulated the following data: the 
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diameter of the virus particle was 1020 A with a radiation-sensitive 
region of 560 A across which was surrounded by a radiation-insensitive 
coat having a thickness of 230 A. Wilson (130) found the hemolytic 
property to reside in about 15 separate target areas covering 15 to 30 
percent of the total surface area. The sites for attachment in hemagglu­
tination were found to be located on two areas of the virus (134). Rubin 
(111) pointed out that in the neutralization reaction the Newcastle dis­
ease virus particle probably had four to six sites for attachment of the 
antibody. A single antibody attached to a virus particle allowed adsorp­
tion to the host cell but prevented infection, while to prevent adsorption 
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of the virus particle all sites must be neutralized (29, 112). 
Protein and nucleic acid have been found in all viruses studied 
although the amounts vary greatly (34). Recent findings indicate that 
Newcastle disease virus contains only RNA (73). This differs from 
earlier reports which described the nucleic acid of the virus to be 
mainly DNA (1, 36). One group of figures lists the virus to contain 27 
percent lipid, 67 percent protein and one percent nucleic acid (119). 
A soluble antigen has been described for the group of myxoviruses 
which is understood to refer to complement-fixing material separable from 
the elementary bodies. Recent work with the influenza virus indicates 
that the soluble antigen is an integral part of the virus particle (93, 
94). The soluble antigen is small, 10 to 15 mj-i, and containing 10 to 15 
percent RNA which appears to be the total amount present in the 
myxoviruses. Antisera for the soluble antigen of one of the viruses of 
the group will give a cross reaction with soluble substance of the other 
viruses belonging to the group. The antibody of the soluble antigen has 
no neutralizing action for the virus particle or the hemagglutinin sub­
stance. The antigen-antibody relationship may be used to demonstrate the 
formation of soluble substances, to indicate viral products or by­
products during multiplication, or for identification of components of 
virus following fractionation. By centrifugation of allantoic fluid of 
Newcastle disease virus infected chicken embryos, Granoff et al. (60, 61) 
demonstrated large and small hemagglutinin substances. The hemolytic 
activity seemed to be associated with only the large component. 
A simple method for propagation of animal viruses in tissue culture 
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was developed in 1907 although it was nearly 20 years later that all 
doubt was removed regarding the multiplication of viruses in tissue 
cultures (48). Although Topacio and Hyde (124) and Huang (74) described 
the action of virus on the host tissue cell, it was not until about 1950 
that the cytopathogenic effect produced by virus during multiplication 
within the tissue culture cell took an important place in virus studies 
(109). 
This was followed by work of Dulbecco (41) and Dulbecco and Vogt 
(42) who developed techniques for plaque formation by animal viruses in 
suitable tissue culture cell monolayers. With this information, the 
tissue culture method was adapted for isolation and identification of 
viruses, titration studies, isolation of pure strains from a single virus 
particle, mechanism of viral infection of the cell and as an aid in 
checking for virus mutations (57). 
Topacio (123) found Newcastle disease virus to be viable in tissue 
cultures having a cell origin from brain, visceral organs, skin and whole 
embryo. The multiplication of the virus was demonstrated in epithelial, 
cancer, liver and intestinal cells of human origin, bovine cells of skin, 
kidneys and muscle, swine tissues, monkey kidney and other type cells 
(6, 12, 30, 43, 44, 45, 121, 125). 
Following the work of Woodruff and Goodpasture (135) in 1931 with 
the chicken embryo, the possibilities of virus techniques in the 
embryonating egg were soon adopted. Burnet and co-workers (24) 
contributed much to the use of the chick embryo technique for quantita­
tive studies of the viruses. Many of the animal viruses were isolated 
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and identified by inoculation of chicken embryos (20). The embryos were 
also used for serum and virus neutralization studies. 
The response of the various biological and serological properties of 
Newcastle disease virus when exposed to heat was brought out previously 
in the literature survey as one of the means of differentiating the 
strains of the virus. The ability of a virus particle or property to 
withstand the stress of heat must be a reflection of some facet of the 
virus structure or composition. Quantitative studies on the thermal in-
activation rates in an attempt to gain knowledge of virus structure have 
been reported. Woese (133) brings out several common characteristics of 
animal virus thermal inactivation. At lower temperatures, single 
component first order inactivation rate curves are observed. At high 
temperatures, two component inactivation rate curves, both first order, 
are observed. The heat of inactivation is low for the single slow 
component at low temperatures and at high temperatures the heat of inac­
tivation is low for the slow component and high for the faster component. 
The intercept of the slow component increases with decreasing tempera­
tures, approaching 100 percent in the high temperature inactivations. 
It was also brought out that the suggested heterogeneity of a virus 
population cannot account for the two component curves observed at 
elevated temperatures, i.e. the two component inactivation rate curves 
for a homgeneous virus population are real. It was postulated that the 
experimental facts reflect the occurrence in the heat inactivation 
process of both heat induced breaks in and/or collapse of virus struc­
tures which result in the loss of a viral property. Therefore, the 
12 
nature of the thermal inactivation rate curve, properly defined with 
respect to the conditions under which it is obtained, becomes a useful 
marker for a virus population and indirectly reflects the nature of 
internal structures. 
The use of ionizing radiation in the study of virus structure was 
cited previously in the work of Wilson and Pollard (131) and Wilson 
(129, 130) in their estimation of both the sizes and numbers of several 
of the measurable components of Newcastle disease virus. The role of 
ionizing radiation, theories, techniques and application to virus 
research has been reviewed extensively by Lea (88) and Pollard (106). 
Ionizing radiations appropriately applied to viruses enable the 
investigator to cause areas or volumes of destruction to occur on the 
surface or within the virus particle (59, 65). If the destructive event 
occurs within or on a unit of a virus that is responsible for some 
measurable property it becomes possible to equate the amount and type of 
radiation applied to the decrease in the measurable property (78). From 
this type of data conclusions can be drawn concerning the size and number 
of areas or volumes associated with the property being evaluated. This 
experimental approach is commonly known as the application of the target 
theory. Lea and Salaman (89) have developed much of the theory back of 
this experimental approach. 
Basically the target theory implies that a single primary ionizing 
event, plus the secondary ionizing events resulting from the primary, 
occur within a finite volume or area and that these events are capable of 
and do cause the inactivation of the property being measured, i.e., a 
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single primary "hit" within a sensitive volume or area will cause the 
inactivation of the property residing in that volume or area. 
Lea (88) states that the usefulness of the theory suffers when 
applied to very large viruses, but that it appears to give very good 
agreement with data obtained by other means with viruses falling in the 
middle ranges of relative virus size. Other workers (86, 87) also ques­
tion the value of the target theory approach to the study of virus 
properties, stressing again the weaknesses observed in applying it to all 
viruses. 
14 
MATERIALS AND METHODS 
Tissue Culture 
Successful tissue culture techniques are particularly dependent upon 
strict adherence to standardized procedures. Solutions, media and gener­
al techniques used in tissue culture work are included in this section. 
Ion exchange water 
In order to have suitable water for the tissue culture studies, it 
was necessary to process the water in the following manner. The water 
was passed through a commercial water softener and then distilled in a 
Barnstead still. This distilled water was further processed by passing 
through a Quikpure Lab-Flow Demineralizer* and stored in polyethylene 
bottles. A Barnstead Model PM-3 purity meter was routinely used to check 
the purity of the water. This was a relative conductivity measurement 
related to NaCl in P.P.M. 
Glassware 
The following method, based on procedures recommended by others (38, 
44, 77), provided satisfactory glassware for the work. All glassware 
after use was rinsed in distilled water and then immersed in plastic 
pails containing a solution of a one percent detergent (Microsolve^) in 
Icomroe Laboratories, Inc., 5208 S. Lakepark Avenue, Chicago 15, 
Illinois. 
^Microbiological Associates, Inc., 4813 Bethesda Avenue, Washington 
14, D.C. 
15 
distilled water to prevent drying of materials in the glassware until a 
subsequent washing. The glassware was thoroughly brushed to remove cell 
debris as it was being taken from these containers and placed in a stain­
less steel pan containing the one percent Microsolve for simmering for 20 
minutes. The glassware was then drained and rinsed three times in ion 
exchange water. To assure thorough rinsing each piece of glassware was 
completely filled and drained during each rinse. Following the third 
rinse, the items were heated in ion exchange water for 20 minutes, 
drained and allowed to dry in a 35°C incubator. Containers used in mix­
ing and storing of media did not receive the last heating. Pipettes 
were washed in an automatic pipette washer, using at least 20 cycles of 
tap water, three rinses of distilled water and a final rinse in ion 
exchange water. Glassware was wrapped or placed in container for 
sterilization in a hot-air oven or an autoclave and stored in closed 
cabinets until used. New glassware was incorporated into the cleaning 
cycle at the rinsing step. 
Solutions 
NaHCOg stock solution A 2.8 percent concentration of NaHCOg was 
made in ion exchange water, dispensed in 25 ml screwcapped tubes, auto-
claved at 118°C for ten minutes and stored at 4°C. 
Phenol red stock solution To 0.4 gm of phenol red was added 
approximately 22 ml of N/20 NaOH. The final volume was brought to 200 ml 
with ion exchange water and the pH adjusted to 7.0 with N/20 NaOH (77). 
The solution was stored at 4°C. 
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Hanks balanced salt solutions A 10X solution was prepared by 
dissolving NaCl—80.0 gm, KC1--4.0 gm, MgS04*7H20--2.0 gm, 
NagHPO^'ZHgO—0.6 gm, glucose—10.0 gm and KH2PO4—0.6 gm in 800 ml ion 
exchange water. To this mixture were added 1.4 gm of CaClg which had 
been dissolved in 200 ml of ion exchange water. The solution was 
dispensed in 100 ml amounts in screwcap bottles and 0.1 ml chloroform 
added to each bottle as a preservative. The product was stored at 4°C 
until used. The Hanks 10X solution was placed in a 37°C water bath for 
15 minutes with the bottle cap loosened to drive off the chloroform 
before use. 
A IX Hanks solution was prepared by mixing 100 ml of the 10X Hanks 
solution and 20 ml of the NaHCO-j stock solution and bringing the total 
volume to 1000 ml with ion exchange water. When phenol red indicator 
was needed 100 ml of the phenol red stock solution was used to replace 
100 ml of ion exchange water. The pH of the solution was adjusted to 7.4 
and sterilized by filtration through a Selas No. 02 filter. The 
sterilized solution was bottled in 100 ml amounts and stored at -20°C 
until used. 
Earle's balanced salt solutions A 10X Earle's solution was pre­
pared by dissolving NaCl—68.0 gm, KC1—4.0 gm, MgSO^—l.O gm, NaHgPO^— 
1.25 gm, glucose—10.0 gm in 800 ml ion exchange water. To this mixture 
was added 2.0 gm of CaClg which had been dissolved in 200 ml of ion 
exchange water. The solution was dispensed in 100 ml amounts in screwcap 
bottles and 0.1 ml chloroform added to each bottle as a preservative. 
The product was stored at 4°C until used. Before using the 10X solution, 
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it was placed in a 37°C water bath to drive off the chloroform. 
A IX solution was prepared by mixing 100 ml of Earle's 10X solution, 
20 ml of NaHCOj stock solution and sufficient ion exchange water to make 
a total of 1000 ml. If needed, 100 ml of phenol red stock solution may 
replace 100 ml ion exchange water. The pH was adjusted to 7.4 and the 
solution sterilized by filtration through a Selas No. 02 filter and 
stored at -20°C until used. 
Dulbecco phosphate buffered saline The phosphate buffered saline 
(100) was prepared by making solution No. 1 containing NaCl--8.0 gm, KC1--
0.2 gm, NagHPO^—1.15 gm, KH2PO4--O.2 gm, in 800 ml ion exchange water. 
If needed, 100 ml phenol red stock solution may replace 100 ml ion 
exchange water. Solution No. 2 contained 0.1 gm of CaCl2 in 100 ml of 
ion exchange water. Solution No. 3 contained 0.1 gm of MgClg'GHgO in 100 
ml ion exchange water. The three solutions were combined and sterilized 
by filtration through a Selas No. 02 filter and stored at -20°C until 
used. 
Calcium and magnesium free saline (GKN) A GKN stock solution was 
prepared by dissolving NaCl—80.0 gm, KC1--4.0 gm, and glucose--10.0 gm 
in 1000 ml ion exchange water. The solution was dispensed in 100 ml 
amounts in screwcap bottles and 0.1 ml chloroform added to each bottle as 
a preservative. The product was stored at 4°C until used. 
The GKN solution was prepared by diluting 100 ml of the stock solu­
tion to 1000 ml with ion exchange water. One hundred ml of phenol red 
stock solution may replace 100 ml of the ion exchange water. The solu­
tion was sterilized with a No. 02 Selas filter and then stored at -20°C 
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until used. 
Cox's buffer Cox's buffer was prepared by adding 9,2 gm 
NaHgPO^'HgO and 34.6 gm NagHPO^'THgO to 2000 ml of distilled water and 
the pH adjusted to 7.0. The solution was sterilized by filtration 
through a Selas No. 02 filter and stored at 4°C in 50 ml amounts. 
Trypsin solution To 885 ml of ion exchange water were added 2.5 
gm of 1-250 trypsin'*', 100 ml of the GKN stock solution, five ml phenol 
red solution, and 10 ml of the antibiotic stock solution. The solution 
was adjusted to pH 8.0 using the NaHCOg stock solution, filtered through 
a No. 02 Selas filter for sterilization, and stored at -20°C in 100 ml 
amounts. 
Antibiotic stock solution One gram of streptomycin and 200 
million units of penicillin were added to 100 ml of 10X Earle's balanced 
salt solution. The solution was filtered through a No. 02 Selas filter 
and stored in 10 ml amounts in screwcapped tubes at -20°C. 
Lactalbumin hydrolysate stock solution To 100 ml of the 10X 
Earle's stock solution were added 900 ml of ion exchange water and 
dispensed in 100 ml amounts in screwcap bottles. Five gm of lactalbumin 
hydrolysate^ was added to each bottle. If desired, one ml of phenol red 
stock solution was added per 100 ml bottle. The lactalbumin hydrolysate 
was suspended by shaking and then autoclaved at 118°C for 10 minutes. 
The bottles were stored at -20°C until used. 
^Trypsin 1:250, Difco Laboratories, Detroit, Michigan. 
^Lactalbumin hydrolysate (enzymatic), Nutritional Biochemicals 
Corporation, Cleveland, Ohio. 
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Neutral red solution One gram of neutral red was added to 1000 
ml of ion exchange water. The mixture was refrigerated for 24 hours with 
occasional stirring to completely dissolve the dye. The solution was 
dispensed in 50 ml and 100 ml amounts in screwcapped bottles, autoelaved 
at 118°C for 10 minutes and stored at room temperature. 
Calf serum Bovine blood was collected in clean stainless steel 
buckets from young healthy animals during slaughter at the University 
abattoir. The blood was allowed to clot at room temperature for six 
hours, the clot was then cut into small pieces with a spatula, refriger­
ated overnight at 4°C and the serum harvested the following day. The 
serum was centrifuged at 4000 rpm (3350 g) for 20 minutes to remove the 
red blood cells and then passed through a series of Selas filters (XXF, 
XF, No. 10, No. 01, No. 015) for further clarification. Sterilization 
of the serum was accomplished by filtration, using a Selas No. 02 filter. 
The sterile serum was placed in 400 ml amounts in screwcapped bottles, 
inactivated at 56°C for 30 minutes and stored at -20°C. 
Chicken embryo extract Eggs were obtained from a white leghorn 
flock maintained at the Veterinary Medical Research Institute. The flock 
was maintained in isolation and was not vaccinated for Newcastle disease. 
The eggs were incubated in a forced air Jamesway incubator at 98-99°F. 
Ten-day old embryonated chicken eggs were used in the preparation of 
chick embryo extract. The fertile eggs were washed with a 1:5000 Roccal^ 
solution and allowed to air dry before disinfecting over the air space 
^Roccal Brand, Winthrop Laboratories, New York 18, New York. 
with 2 percent tincture of iodine. The shells were cracked and removed 
from over the air spaces and the shell membranes were torn from over the 
embryos with sterile forceps. The embryos were extracted from their 
attachments by exerting gentle upward traction and transferred to a 
sterile petri dish containing cold GKN solution. After rinsing well to 
remove any blood or yolk from the surface of the embryo, they were placed 
in a 20 ml syringe containing a wire screen. The plunger was adjusted to 
the barrel of the syringe and the tip of the latter inserted into a 
sterile, screwcap, centrifuge tube to receive the expressed embryo 
tissues. The amount of minced embryonic tissue was determined and an 
equal volume of Hanks balanced salt solution was added. The mixture was 
placed in a 4°C water bath for a 30 minute incubation period during which 
time the centrifuge tube was inverted several times. The mixture was 
centrifuged for 30 minutes at 2000 rpm (900 g). The supernatant fluid 
was dispensed into 16x125 mm screwcap tubes and stored at -20°C. 
Media 
Growth medium E The following ingredients were combined and 
brought to a final volume of 1000 ml with ion exchange water: 100 ml of 
lactalbumin hydrolysate stock with phenol red, 80 ml of 10X Earle's solu­
tion with phenol red, 100 ml calf serum, 10 ml antibiotic stock solution, 
and approximately 20 ml of NaHCOg stock solution to bring the pH to 7.4. 
The solution was filter sterilized with a No. 02 Selas filter and stored 
in 400 ml screwcapped bottles at -20°C until used. 
Growth medium H The medium was prepared by mixing 100 ml 
lactalbumin hydrolysate stock with phenol red, 80 ml 10X Hanks solution 
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with phenol red, 100 ml calf serum, 10 ml antibiotic stock solution, 
approximately 20 ml of NaHCO^ stock solution and the total volume made up 
to 1000 ml. The pH was adjusted to 7.4, solution was filter sterilized 
with a Selas No. 02 filter and was stored in 400 ml amounts in screwcapped 
bottles at -20°C. 
Mixture 199 Morgan et al. (102) described a chemically defined 
medium for tissue culture work. This medium was purchased from a commer­
cial source^ as mixture 199 10X. The 10X concentrate was diluted 1:10 
with sterile ion exchange water and the pH adjusted to 7.4 with the 
NaHCOg stock solution. 
Lactalbumin hydrolysate maintenance medium A 2X maintenance 
medium was prepared by combining 100 ml of lactalbumin hydrolysate stock 
without phenol red, 80 ml of 10X Earle's solution without phenol red, 60 
ml of calf serum, 10 ml of antibiotic stock solution, 20 ml of a NaHCOg 
stock solution and sufficient ion exchange water to bring the final 
volume to 500 ml. The solution was adjusted to pH 7.4, filter sterilized 
with a No. 02 Selas filter and stored at -20°C. 
Lactalbumin hydrolysate overlay medium The 2X maintenance medium 
9 
was mixed with an equal amount of a 1.5 percent Noble Agar at a tempera­
ture of 45°C and seven ml of chick embryo extract were added to each 100 
ml of the mixture. 
^Mixture 199 10X, Microbiological Associates, Inc., 4813 Bethesda 
Avenue, Washington 14, D.C. 
n 
Special Agar-Noble, Difco Laboratories, Detroit, Michigan. 
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Growth of tissue culture cells 
Chicken embryo fibroblasts Eggs were obtained from the same 
source as described in chick embryo extract. When the embryos were 10 
days of age the fertile eggs were cleaned with an alcohol swab and the 
shells removed from over the air-sacs. Using sterile thumb forceps the 
shell membranes were removed from over the embryos, the latter were de­
capitated and the bodies were placed in sterile petri dishes containing 
GKN solution warmed to 40°C. The embryos were washed to remove extrane­
ous materials, eviscerated and transferred to other petri dishes 
containing the GKN solution. The remaining portion of the embryos were 
forced through a glass syringe containing a 16 mesh copper wire screen. 
The minced tissues were collected in a glass beaker in which they were 
washed in the GKN solution, allowed to settle for 15 minutes, the 
supernatant fluid poured off, and the procedure repeated to remove the 
cellular debris. After decanting the second washing fluid, the remaining 
tissues were transferred to a trypsinization flask^. 
Approximately 10 parts of the trypsin solution were added to one 
part of tissues and trypsinization carried out at 40°C for 20 to 30 
minutes while being agitated with a magnetic stirrer. If the pH of the 
solution dropped, the trypsin was poured off and replaced with fresh 
trypsin in order to complete the process as quickly as possible. The 
decanted solution was refrigerated at 4°C immediately to stop the action 
of the trypsin. 
*No. 14-2253 trypsinizing flask, Bellco Glass, Inc., Vineland, New 
Jersey. 
23 
Following trypsinization, the solution was filtered by passing 
through four thicknesses of sterile cheesecloth to remove any remaining 
large pieces of tissue. The cells were packed by centrifugation for 15 
minutes at 1200 rpm (350 g) in a refrigerated centrifuge at 8°C. The 
trypsin solution was poured off and the cells washed by resuspending in 
growth medium E at 8°C temperature, centrifuged at 600 rpm (95 g) for 
three minutes, the supernatant decanted and the washing procedure repeat­
ed. Care was taken to remove blood cells and debris with the supernatant 
by controlling the speed and time of centrifugation and careful pipetting 
of the supernatant (49, 50). 
A final cell concentration of one part packed cells in 200 parts of 
growth medium E was made and dispensed at the rate of five ml per 60 mm 
petri dish or 13 ml per 100 mm petri dish. Both glass and plastic^ petri 
dishes were used. A suspension of one part packed cells and 300 parts of 
growth medium E was used for tube cultures (46). Two ml of the suspen­
sion were added to each of the 16x150 ram culture tubes which were closed 
with rubber stoppers and placed on a slant in a culture test tube rack 
for incubation. 
The cell cultures were incubated at 35°C in an atmosphere of 4.5 
percent carbon dioxide. A water jacketed incubator was equipped with two 
flowmeters so that carbon dioxide and air were measured into the incubator 
at a rate to create an atmosphere containing the desired amount of carbon 
dioxide. Removable trays were used for holding the plates during 
•'•No. 3002, Falcon Plastics Company, Division of Bee ton, Dickinson 
and Company, 6020 W. Washington Boulevard, Culver City, California. 
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incubation, Figs. 1 and 2. 
HeLa cell culture The HeLa cell culture was secured from 
Dr. C. L'Ecuyer. •*" Serial passages of the HeLa cells were made at weekly 
intervals. The growth medium H was decanted from the cultures and the 
monolayers washed with GKN solution and the latter then decanted. Five 
ml of trypsin were added to a 12 ounce culture bottle and incubated at 
room temperature until the cells were detached from the glass. The 
trypsin-cell mixture was then poured into a trypsinization flask and 
trypsinization of the cells continued with the aid of the magnetic 
stirrer. When this was accomplished, growth medium H was added to the 
cell suspension at the rate of 15 ml fluid for each ml of dispersed cells. 
Fifteen ml of the cell suspension were pipetted into a clean 12 
ounce prescription bottle or five ml into each 60 ml petri dish and then 
incubated at 35°C in the carbon dioxide atmosphere. After 48 hours of 
incubation it was necessary to change the medium and incubate for another 
48 hours in order for a complete monolayer to be formed. 
Plaques 
Plaque formation The plaque technique was used for virus titra­
tion studies and also for the isolation of pure strains from individual 
plaques. For this work it is important to have plates containing young 
actively growing tissue cells which are not too tightly packed together 
in the monolayer, Figs. 3 and 4. 
•4)r. C. L1Ecuyer, Veterinary Research Institute, Iowa State 
University, Ames, Iowa. 
Fig. 1. Incubator 
Fig. 2. Tray of plates 

Fig. 3. Monolayer of chicken embryo fibroblasts. X36 
Fig. 4. Monolayer of chicken embryo fibroblasts. X65 
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The medium in the plates was removed by aspiration and the cell 
sheets were checked microscopically to ascertain if a monolayer of cells 
was present. If present, the cultures were then washed with phosphate 
buffered saline and the rinse solution removed. 
Tenfold dilutions of the virus to be assayed were made in phosphate 
buffered saline containing two percent calf serum. Then 0.2 ml of the 
virus dilution were added to each of five washed plates. A series of 
dilutions was used so that plates with a countable number of plaques 
would be available. 
The inoculated plates were incubated for 45 minutes at 35°C to allow 
time for attachment of the virus to the cells, during which time the 
trays of plates were rotated every 15 minutes to aid in the adsorption of 
the virus. After adsorption, five ml of the lactalbumin hydrolysate 
overlay medium were added to each plate and allowed to congeal before 
returning the plates to the carbon dioxide incubator. After three days 
of incubation in an inverted position, one ml of the neutral red-agar 
overlay was added to each plate which was then incubated for four hours 
and the plaques counted. 
Plaque counting Plates having from one to 75 plaques were count­
ed and the number of plaques per plate was recorded. The average number 
of plaques per plate for a given dilution was determined. Dilutions 
having an average of less than one plaque per plate were not used in 
determining the number of plaque forming units (PFU) per ml of virus. 
The average plaque count per plate was multiplied by 5 because only 0.2 
ml of a virus dilution had been used to infect the plate. The appropri­
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ate dilution factor was incorporated to determine the number of PFU per 
ml. When more than one dilution had countable plates, the arithmetical 
average of the dilutions was determined and used for the number of PFU 
per ml. From this count the logarithmic titer of the PFU was determined 
from a four-place logarithm table. The decrease in titer of the 
logarithm to the base 10 of PFU per ml was figured by subtracting the 
logarithmic titer of the different counts from the control count of a 
given experiment. 
Plaque harvesting Plaques to be harvested were removed from the 
plate by cutting around the margin of a plaque with a sterile No. 11 
Bard Parker blade. The plaque was transferred on the point of the blade 
to five ml of phosphate buffered saline with two percent serum and stored 
at -20°C until used. 
Viruses 
Newcastle disease virus strains used in this work were supplied by 
Dr. M. S. Hofstad^ from virus stocks maintained at the Veterinary Medical 
Research Institute. The substrains supplied and their relationship to 
parent stock strains are presented in Table 1. 
The paired substrains supplied had been derived from the parent 
strains in the following manner. The parent virus strain was diluted in 
serial tenfold dilutions and inoculated into 10 day-old chicken embryos. 
Allantoic fluid was collected from individual dead embryos at the 50 
^Dr. M. S. Hofstad, Veterinary Medical Research Institute, Iowa 
State University, Ames, Iowa. 
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Table 1. Newcastle disease virus substrains supplied and their 
parent stock 
Substrains supplied Parent stock strain 
174 HA heat resistant3 174 Iowa 174 HA heat sensitive*3 
982 HA heat resistant 
982 HA heat sensitive Texas DK1155 
GB HA heat resistant 
GB HA heat sensitive GB Texas 
608 HA heat resistant 
608 HA heat sensitive Manhattan, Kansas 
608 atypical0 
909d B1 
aHemagglutinating property heat resistant. 
^Hemagglutinating property heat sensitive. 
cHemagglutinating property exceptionally heat resistant, 
isolated from a heat-stressed 608 HA heat sensitive substrain. 
^Hemagglutinating property heat sensitive. 
percent end-point dilutions. 
Allantoic fluid from individual embryos was heated in a 56°C water 
bath for varying periods of time and the hemagglutination titers deter­
mined for each. Isolates were selected on the basis of the hemagglutina­
tion susceptibility to heat with the most sensitive and resistant ones 
being selected. The above procedure was repeated on those selected until 
the hemagglutination heat sensitive and hemagglutination heat resistant 
substrains were developed. The 909 parent could not be divided into heat 
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sensitive and heat resistant hemagglutination substrains. 
Hemagglutination of chicken red blood cells did not occur after 
heating the heat sensitive substrains at 56°C for 10 minutes. After 
heating the heat resistant substrains at 56°C for 60 minutes, 
hemagglutination of chicken red blood cells still occurred. 
A supply of the virus strains was prepared by inoculating 10 day-old 
chicken embryos with 0.1 ml of a 10"^ dilution of the virus. After 
incubation for 40 hours, the eggs were chilled and the allantoic fluids 
harvested and checked for hemagglutination and bacterial contamination. 
If they were free of bacterial contamination and hemagglutination posi­
tive, the allantoic fluids for each virus strain were pooled, dispensed 
in 10 ml amounts into sterile screwcap vials and stored at -20°C until 
used. 
Serology 
Reagents 
Alsever's solution To 100 ml ion exchange water were added 2.05 
gm dextrose, 0.8 gm Na citrate, and 0.42 gm NaCl. The solution vras 
adjusted to a pH of 6.1 with citric acid, sterilized by filtration 
through a Selas No. 02 filter and stored at 4°C. 
Cox's buffered saline Fifty ml of Cox's buffer, 10 ml Merthiolate 
(1:1000, stainless) were added to 940 ml of 0.85 percent saline solution. 
The solution was kept in the 4°C refrigerator. 
Cox's buffered saline with serum One part of normal serum was 
added to 999 parts of Cox's buffered saline. The solution was stored at 
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4 C until used for diluting the red blood cells used in the hemagglutina­
tion test. The serum and red blood cells belonged to the same animal 
species. 
Citrated physiological saline Physiological saline was prepared 
by adding 0.85 gm of NaCl to 100 ml of distilled water. To 100 ml of the 
physiological saline were added 2 gm of sodium citrate and the pH 
adjusted to 7.4 with 0.10M phosphate buffer solution (Cox). The solution 
was stored at 4°C. 
Saponin Saponin^ was purchased as a purified powder. 
Red blood cells The blood was collected in alsever's solution 
for preparation of red blood cells. Turkeys were bled from a wing vein 
and chickens were bled from the heart. 
The cells for the hemagglutination test were washed twice in 
alsever's solution and then stored at 4°C as a 10 percent red blood cell 
suspension in alsever's solution. The cells were centrifuged at 1500 rpm 
(530 g) for 15 minutes. 
The chicken red blood cells for the hemolytic tests were prepared 
from freshly drawn blood. After the first centrifugation the red blood 
cells were resuspended in the citrated physiological salt solution. 
Hemagglutination test 
The hemagglutination tests were set up in 12x75 mm Kimax culture 
tubes. Starting with a 1:5 dilution of the virus preparation to be 
^Fisher Scientific Company, 1458 N. Lamon Avenue, Chicago 51, 
Illinois. 
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evaluated, serial twofold dilutions of the virus were made in 0.5 ml 
volumes of Cox's buffered saline. Turkey red blood cells, 0.5 ml of a 
0.3 percent suspension in Cox's buffered saline with turkey serum, were 
thoroughly mixed with each dilution. The tests were incubated for two 
hours at 4°C. At the end of the incubation period, the test results 
were scored as negative or positive (69). Saline-red blood cell 
controls were included with each series to check for false hemagglutina­
tion and as an indicator for the rate of settling of the red blood cells 
(52, 53). 
Hemolysin assay procedure 
The viruses for hemolysin studies were taken from the various virus 
pools. They were thawed in a 37°C water bath and then placed in 
cellulose casings for dialysis. 
Dialysis was carried out at a temperature of 4°C with the aid of 
mechanical agitation. The first dialyzing solution was distilled water 
which was changed every six hours. Usually after 12 hours of dialyzing, 
the phenol red indicator was gone from the tissue culture fluids. When 
the solution was clear, the distilled water was replaced with a two per­
cent citrated saline solution and this solution was changed once during 
the remaining 12 hours of dialysis. Infected allantoic fluid was 
dialized for 12 hours in the distilled water and for 12 hours in citrated 
saline. 
Lyophilization of the dialized material was the next step in the 
preparation of the virus for hemolysin studies. This process was carried 
out under vacuum with a dry ice-alcohol bath serving to keep the 
condenser chamber cold. With the equipment used it was possible to dry 
the material in five to six hours of lyophilization. The sealed tubes 
containing the lyophilized viruses were stored at 4°C until used. 
The lyophilized virus was reconstituted in two percent citrated 
saline solution for irradiation and heat studies. Following exposure, 
twofold dilutions of the virus were made in one ml volumes in citrated 
saline in 13x150 caliberated test tubes. 
The chicken red blood cells were washed twice in citrated salt 
solution and following the last centrifugation a one percent red blood 
cell suspension was made in the citrated physiological saline. 
The virus dilutions and red blood cell suspension were warmed in 
37°C water bath and one ml of the red blood cells was added to each tube 
of the virus dilutions. The virus-red blood cell mixture was then 
incubated in the 37°C water bath for one hour. After this incubation 
period, the tubes were removed from the water bath and one ml of the cold 
citrated saline solution was added to each tube to stop the hemolytic 
reaction. 
Two controls were used for each series of tests. One control 
consisted of one ml of the red blood cell suspension in one ml of the 
citrated saline. The other control was one ml of the red blood cells 
plus one ml of distilled water and a minute amount of saponin. The 
latter produced complete hemolysis of the red blood cells. Both controls 
were incubated along with the virus dilutions and the cold saline was 
added to them at the end of the incubation period. 
Following incubation, the intact red blood cells and stroma were 
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packed by centrifugation for five minutes at 1500 rpm (500 g) so that the 
hemolysin activity could be determined in a spectrophotometer^, with a 
wave length setting of 540 millimicrons. The machine was adjusted to 
infinity and the proper setting made for the red cell-saline control. 
The optical density reading for the complete hemolysin control was then 
made, followed by readings for the rest of the tubes. 
Neutralization procedure 
Newcastle disease virus antiserum was produced in young male 
rabbits. The parent virus strains were used to stimulate antibody 
production. Three ml of infected allantoic fluid were injected intra­
venously into the animals on three alternate days. The series of 
inoculations were made intraperitoneally the following week using the 
same dosage and time schedule. During the third week, the antigen was 
again given by the intravenous route. Three days later a five ml dose 
of the virus solution was given intraperitoneally. Seven days after this 
inoculation the rabbits were bled from the heart, the blood allowed to 
clot and the sera harvested. The sera were inactivated at 56°C for 30 
minutes and stored at -20°C. 
In performing the virus neutralization test, the antisera were 
diluted in twofold dilutions in phosphate buffered saline. A tenfold 
dilution of the appropriate virus was made in the phosphate buffered 
saline. A 0.5 ml amount of the 10"^ and 10"^ virus dilutions was mixed 
with an equal amount of the antisera dilutions. The virus-antiserum 
ISpectonic 20 colorimeter, Bausch and Lomb Optical Company, 
Rochester 2, New York. 
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mixtures were incubated at 25°C for 60 minutes. Five plates of HeLa cell 
monolayers were inoculated with 0.2 ml of each of the virus-serum 
mixtures. After allowing 45 minutes for adsorption at 35°C, the cultures 
were overlaid with five ml of lactalbumin hydrolysate overlay medium. 
Neutral red-agar mixture was added to the plates after 72 hours incuba­
tion. Plaques were harvested from the highest dilutions and stored at 
-20°C until used. 
Heat inactivation procedures 
Heat inactivations were conducted in a 10 gallon constant tempera­
ture water bath controlled by a bi-metallic thermoregulator coupled to a 
sensitive relay. Vigorous mechanical agitation was accomplished by a 
motor driven stirrer. The temperature was maintained at the specified 
temperature +0.02°C. 
Samples of the respective virus substrains were taken from storage 
and thawed in a 37°C water bath. One ml amounts were placed in sterile 
one dram, soft glass screwcapped vials. Care was taken to insure that 
none of the virus material came in contact with the upper walls of the 
vials. Samples were brought to 20°C, placed in retention racks and sub­
merged in the water bath for the proper time. Upon removal from the bath, 
the samples were placed in a water-ice mixture to facilitate rapid cool­
ing. Controls were handled in an identical manner, eliminating only the 
heating step. The vials were opened under aseptic conditions and the 
appropriate dilutions made for assay. 
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Radiation procedure 
Co^ gamma radiation facility The source of gamma radiation was 
the Veterinary Medical Research Institute Co^® irradiation facility. The 
facility consists of a lead shielded irradiation chamber containing a 6-
membered variable diameter ring-source holder mechanism loaded with the 
six capsules containing about 170 curies of Co^ each. The sample 
carrier is attached to a lead filled cylinder which gains access to the 
irradiation chamber through a 4-1/2 inch lead shielded access tube. The 
sample chamber used for these studies consisted of a dewar flask of 
special design filled with liquid nitrogen. Samples were presented to 
the personnel of the unit for irradiation. Following irradiation the 
samples were stored in the nitrogen refrigerator until assayed. 
Dosimetry of radiation Dosimetry was accomplished by the 
facility personnel using the Fricke Fe"1"*" -Fe'1'1'1 dosimeter. Dosimetry 
solutions, 0.6 ml, were placed in vials identical with the ones to be 
used for the virus irradiations, irradiated for appropriate times, read 
in the Beckman DU spectrophotometer and dose rates calculated in rads per 
minute as of the day of dosimetry. Conversions were made to the dose rate 
on the day of irradiation of the virus preparations by a formula based on 
the known decay rate of Co^O. The dose rate determined on March 9, 1961 
was 13,900 rads/minute plus 300 rads received during sample placement and 
withdrawal. 
Sample preparation Samples of the respective virus substrains 
were taken from storage, thawed in a 37eC water bath. 0.5 to 0.6 ml was 
placed in sterile 4-1/2 inch 5 mm O.D. pyrex vials by means of a syringe 
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fitted with a 4 inch 20 gauge needle. Care was taken to prevent liquid 
from touching the upper half of the vial walls during filling. After 
being filled, the tubes were sealed off with an oxygen-gas torch. The 
filled vials were quick frozen in liquid nitrogen and placed in the 
liquid nitrogen refrigerator. After irradiation, at dose rates and times 
specified, the vials were returned to the nitrogen refrigerator until 
assay. Controls were handled in an identical manner eliminating only the 
irradiation step. At the time of assay, samples were thawed for 30 
seconds at 37°C, opened under aseptic conditions and diluted appropriate­
ly for assay. Radiation facility personnel supplied copies of the 
irradiator log indicating the times the samples were irradiated and the 
dose rate on the day of irradiation. 
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EXPERIMENTAL RESULTS 
It was initially necessary to establish that the Veterinary Medical 
Research Institute Newcastle disease virus substrains would produce a 
detectable cytopathogenic effect in monolayer tissue cultures of chicken 
embryo fibroblasts. If cytopathogenic effect occurred then it should be 
possible to isolate for use in this study a substrain of each virus by 
the plaque technique. 
The virus substrains (174 HA resistant and sensitive, GB HA 
resistant and sensitive, 982 HA resistant and sensitive, 608 atypical and 
909) were diluted serially and chicken embryo fibroblasts were infected 
with each substrain using 10"''" through 10"^® dilutions. Following 
adsorption of the virus and addition of the maintenance medium, the 
plates were incubated for 72 hours before adding the neutral red-agar 
overlay. After four hours of further incubation the plates were examined 
for presence of plaques. 
Plates infected with the lower dilutions had the entire cell sheet 
destroyed while the lO~^° dilutions were usually free of any plaques 
because of the absence of virus. The countable plates appeared at the 
10"6 to 10"^ dilutions. The plaques were examined for size, completeness 
of damage to the tissue cells and the plaque count was recorded. Sub­
strain 909 did not form plaques under the conditions employed and had to be 
evaluated separately by another approach. 
The plaques observed were clear and had a distinct edge with all of 
the cells in the plaque area destroyed. The plaques varied in size and 
were scored into three groups based upon the diameter of the plaque. 
Small plaques were those measuring 0.7 mm or less, medium plaques were 
from 0.75 to 1.75 mm and large plaques had a diameter of 1.8 mm or more. 
The plaques of the various substrains were very similar in appear­
ance and in the relative percentage of the different plaque sizes 
present. Two plaques of each size group from each substrain were 
harvested from the first passage. 
For the second tissue culture passage, tenfold dilutions were made 
from each harvested plaque and the chicken embryo fibroblasts infected 
with the 10"2 through 10""' dilutions. Again the plaques were examined 
and harvested as in the first passage. A third tissue serial passage in 
chicken embryo fibroblasts was made using the same procedure as for the 
second passage. 
The data from the three serial passages through tissue culture of 
the 174 HA heat resistant substrain are presented in Table 2. These 
data are representative of the data obtained for all of the substrains, 
showing the distribution of the small, medium and large plaques and the 
definite trend toward increasing percentages of the small plaques with 
each passage. From each of the substrains two plaques from each plaque 
size classification were harvested from the third serial passage and 
stored at -20°C. These tissue culture derived substrain isolates were 
temporarily identified as 174-R small, 174-R medium, 174-R large: 174-S 
small, etc., with the -R signifying heat resistance and the -S signifying 
heat sensitivity based upon the heat sensitivity designation of the 
original substrain. In addition to the 174 substrains the GB and 982 pairs 
and the 608 atypical substrains were passaged and evaluated. 
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Table 2. Distribution of plaque size during three serial passages of 
Newcastle disease virus in chicken embryo fibroblasts, 174 
HA heat resistant substrain 
Tissue 
culture 
passage 
number 
Plaque 
size 
observed Small 
Plaque size 
(percent) 
Medium Large 
Total number 
plaques 
counted 
1 50 30 20 204 
2 Small 79 21 0 317 
Medium 65 31 4 326 
Large 53 38 9 279 
3 Small 93 7 0 342 
Medium 85 12 3 303 
Large 76 16 8 287 
As previously noted, 909 was the only substrain that did not produce 
plaques in the chicken embryo fibroblast test system. Since it was 
possible that this substrain was multiplying in the chicken embryo 
fibroblasts without causing plaque formation, an attempt was made to 
establish whether multiplication was occurring without this observable 
cytopathogenic effect. A 0.2 ml amount of 10"^ dilution of substrain 
909 in allantoic fluid was used to infect monolayers of chicken embryo 
fibroblasts on plates. Liquid medium was added and incubation was 
carried out for 72 hours. The fluids were harvested for serial passage. 
Two additional passages were made using 0.2 ml of a 10 ^ dilution of 
harvested fluids for infecting the cells. Fluids harvested from the 
third passage were stored at -20°C until used. Fluids from uninoculated 
plates carried through three passages were used as controls. Both 
hemagglutination titers and infectivity titers obtained by the chicken 
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embryo technique were made to determine if multiplication of the 909 
virus had taken place without gross cytopathogenic effect to the cells. 
Hemagglutination titers of 1:160 and chicken embryo infective titers of 
10 ^  indicated that a reasonable multiplication of the virus had occurred 
in the tissue culture system. The fluids from the uninoculated plates 
did not cause hemagglutination, produce any changes in chicken embryos 
nor did the allantoic fluids from these embryos cause hemagglutination. 
In order to establish for the tissue culture propagated substrains 
whether their hemagglutination property, heat sensitivity or heat 
resistance, had been altered by tissue culture passage, the plaque 
isolates from the third passage were propagated in tissue culture cells 
with liquid medium and the pools assayed for the heat stability of the 
hemagglutinating property. 
For comparative purposes the original egg embryo derived virus sub­
strains were evaluated in a similar manner. The 909 substrain propagated 
in tissue culture media was also checked against its original substrain. 
The results of this study are presented in Table 3. Examination of the 
data reveals that no changes in the nature of thermostability of the 
hemagglutinating property of the various substrains occurred. It was 
also interesting to note that plaque size did not appear to influence the 
thermostability of the hemagglutinating property. 
It was decided to use for subsequent studies only the populations 
derived from the small plaque isolates since these isolates produced a 
more homogeneous population based on the criteria of plaque morphology. 
The various virus pools were prepared, dispensed in 10 ml amounts and 
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Table 3. Virus hemagglutination of turkey red blood cells following 
heating at 56°C 
Virus substrains 
Egg embryo Tissue culture 
Minutes Minutes 
Virus 0 10 60 Virus 0 10 60 
174 HA 
heat resistant + 
174-R small 1 + + + 
2 + + + 
medium 1 + + + 
2 + + + 
large 1 + + + 
2 + + + 
174 HA 
heat sensitive 
174-S small 1 + 
2 + 
medium 1 + 
2 + 
large 1 + 
2 + 
GB HA 
heat resistant 
GB-R small 1 
2 
medium 1 
2 
large 1 
2 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
GB HA 
heat sensitive 
GB-S small 1 
2 
medium 1 
2 
large 1 
2 
+ 
+ 
+ 
+ 
+ 
+ 
982 HA 
heat resistant 
982-R small 1 + + + 
2 + + + 
medium 1 + + + 
2 + + + 
large 1 + + + 
2 + + + 
Table 3. (Continued) 
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Virus substrains 
Egg embryo Tissue culture 
Minutes Minutes 
Virus 0 10 60 Virus 0 10 60 
982 HA 
heat sensitive 
+ 
608 
atypical 
909 
982-5 small 1 + - -
2 + - -
medium 1 + - -
2 + - -
large 1 + - -
2 + - -
608 
atypical R 
small 1 + + + 
2 + + + 
medium 1 + + + 
2 + + + 
large 1 + + + 
2 + + + 
909 (pool) + 
stored at -20°C until used. The previous identifications assigned to the 
substrains were continued, i.e., the substrains designated -R have heat 
resistant hemagglutinating properties and those designated -S have heat 
sensitive hemagglutinating properties. The 608 atypical substrain was 
designated as 608 atypical-R and the 909 as 909-S to indicate the heat 
sensitivity of their hemagglutinating properties. 
Heat stress of virus properties 
Hemagglutinating property A quantitative study of the heat 
sensitivity of the hemagglutinating property of each substrain was under­
taken to determine in more detail the heat inactivation characteristics 
of the property. The results obtained are presented in Table 4 and 
include the substrain studied, the length of time heated and the hemag­
glutination titers. Control titers of the tissue culture substrains were 
positive at the 1:160 dilution. Seldom was a 1:320 dilution positive or 
a 1:100 dilution negative. The differences in the thermostability of the 
heat sensitive and heat resistant substrains are clearly demonstrated by 
the data in the table. For the heat sensitive substrains the hemagglu-
Table 4. Virus hemagglutinin stability at 56°C 
Time in minutes 
Virus substrain 0 5 10 30 60 75 90 105 120 150 180 
174-R 160 160 160 160 160 160 160 100 80 10 0 
174-S 160 80 0 0 0 0 0 0 0 0 0 
GB-R 160 160 160 160 100 80 80 40 0 0 0 
GB-S 160 40 0 0 0 0 0 0 0 0 0 
982-R 160 160 160 160 160 100 100 80 10 0 0 
982-5 160 80 0 0 0 0 0 0 0 0 0 
608 atypical-R 160 160 160 160 160 160 160 160 160 100 100 
909-S 160 80 0 0 0 0 0 0 0 0 0 
tination titers are decreasing after five minutes of heating and are 
negative after 10 minutes at 56°C. The heat resistant groups retain 
their titers for longer periods of time with the GB-R substrain falling 
off in titer more rapidly and the 608 atypical-R being much more resist­
ant to heat. 
Two explanations could be offered for the marked differences in 
the heat sensitivity of the hemagglutinating property of the virus sub­
strains. The hemagglutinin structures may actually be different in 
their ability to withstand the stress of heat, the -R substrains having 
a more heat resistant hemagglutinin than the -S substrains. 
The other possibility is that the structure of the hemagglutinins is 
identical but some other aspect of the virus structure may differ in its 
ability to withstand the stress of heat. Some change in this aspect of 
the virus structure due to the stress of heat could either destroy the 
hemagglutinin or prevent its activity. In this case the -R and -5 sub­
strains would have equally heat sensitive hemagglutinins but they could 
still differ in the heat sensitivity of their hemagglutinating properties. 
Evaluations of the heat stabilities of other viral properties of the 
-R and -S substrains should give an indication as to which of the two 
explanations is the more logical. 
Infective property Heat inactivation rate studies were carried 
out in duplicate for each virus substrain to determine the effect of heat 
stress on infectivity. After appropriate periods of heating the plaque 
technique was used to assay the infectivity titers. 
Tables 5 through 11 present the data obtained for the substrains 
studied. The viruses were heated at 56°C for various lengths of time 
and the plaque forming units per ml were determined. The titer 
decreases, expressed as log^Q PFU/ml, are presented for comparison be­
tween duplicate experiments and between substrains. Inspection of the 
data indicates that the agreement between duplicate experiments is quite 
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Table 5. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat resistant substrain 174 
Time 
(minutes) 
Exp. 
Titer 
(PFU/ml) 
1 Exp. 2 
Decrease in titer 
(LogjLQ PFU/ml) 
Exp. 1 Exp. 2 
Control 3.43 X 107 2.19 X 107 
5 min. 1.89 X 107 9.00 X 106 0.26 0.39 
10 min. 2.32 X 107 1.64 X 107 0.17 0.13 
20 min. 1.80 X 10 6 1.36 X 107 1.28 0.21 
30 min. 3.66 X 105 1.56 X 105 1.97 2.15 
45 min. 1.10 X 105 6.90 X 104 2.49 2.50 
60 min. 3.08 X 104 1.98 X 104 3.05 3.04 
75 min. 4.39 X 103 6.55 X 103 3.89 3.52 
90 min. 1.34 X 104 2.92 X 103 3.41 3.88 
105 min. 1.22 X 103 9.70 X 102 4.45 4.35 
120 min. 7.55 X 10 2 6.70 X 101 4.66 5.51 
150 min. 9.45 X 101 5.20 X 101 5.56 5.62 
180 min. 8.20 X 101 2.00 X 101 5.62 6.04 
satisfactory considering the limitations of the assay method. 
Figs. 5 and 6 present graphically the data for the heat inactivation, 
rates of the 174-R and 174-S substrains. Curves, bi-phasic in nature, 
for the inactivation rate and for duplicate experiments are similar. 
Fig. 7 presents a comparison between the 174-R and the 174-S substrains. 
The 174-S substrain is definitely more heat sensitive than the 174-R 
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Table 6. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat sensitive substrain 174 
Decrease in titer 
Time (PFU/ml) (Logip PFU/ml) 
(minutes) Exp. 1 Exp. 2 Exp. 1 Exp. : 
Control 6.25 x 107 4.60 x 107 
5 min. 1.35 x 107 1.11 x 107 0.67 0.62 
10 min. 1.81 x 10 6 1.77 x 106 1.54 1.41 
15 min. 6.75 x 105 3.00 x 105 1.97 2.19 
20 min. 2.48 x 105 8.80 x 104 2.40 2.72 
25 min. 9.45 x 104 3.54 x 104 2.82 3.11 
30 min. 3.30 x 104 3.00 x 104 3.28 3.19 
45 min. 1.04 x io4 1.32 x 104 3.78 3.54 
60 min. 3.78 x 103 1.70 x 103 4.22 4.43 
90 min. 1.36 x 103 6.4 x 102 4.66 4.86 
120 min. 5.80 x 101 4.70 x 101 6.03 5.99 
substrain. 
The data for the GB substrains are presented in a similar manner in 
Fig. 8. Again the bi-phasic nature of the inactivation rate curves is 
noted. The GB-S substrain is definitely more sensitive to heat than the 
GB-R substrain. 
The 982 substrains are compared in Fig. 9. The bi-phasic nature of 
the 982-R substrain inactivation rate curve is quite well defined but is 
not as evident in the curve of the data for the 982-S substrain. Again 
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Table 7. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat resistant substrain GB 
Time 
Titer Decrease in titer (Log10 PFU/ml) 
(minutes) Exp. 1 Exp. 2 Exp. 1 Exp. 
Control 2.49 x 108 3.25 x 108 
10 min. 2.08 x 108 8.5 x 107 0.08 0.58 
20 min. 1.0 x 108 5.25 x 107 0.40 0.79 
30 min. 7.23 x 10 6 1.15 x 107 1.54 1.45 
40 min. 2.21 x 106 7.75 x 105 2.07 2.62 
60 min. 1.48 x 105 5.25 x 104 3.23 3.79 
80 min. 9.25 x 104 1.28 x 104 3.43 4.40 
100 min. 1.31 x 104 6.5 x 103 4.28 4.70 
120 min. 3.00 x 103 1.38 x 103 4.92 5.37 
140 min. 1.76 x 10 2 5.5 x 10 2 6.15 5.77 
180 min. 8.54 x 101 2.0 x 102 6.47 6.21 
the differences in heat sensitivity of the two substrains is evident. 
Finally in Fig. 10 the duplicate experiments for the 608 atypical-R are 
presented. The fact that this substrain is atypical is noticed when it 
is compared with other -R substrains. The slope of the inactivation 
rate curve is much less for this substrain than for any of the others. 
The data also suggest a slight bi-phasic nature for the inactivation 
rate curve. This latter fact is of interest because Hofstad and 
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Table 8. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat sensitive substrain GB 
Titer Decrease in titer 
Time (PFU/ml) (L°§lQ PFU/ml) 
(minutes) Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 1.3 X 107 1.36 X 108 
5 min. 5.5 X 105 2.91 X 106 1.37 1.67 
10 min. 5.88 X 104 7.38 X 105 2.35 2.27 
15 min. 1.38 X 104 2.39 X 105 2.97 2.76 
20 min. 6.5 X 10 3 4.25 X 104 3.3 3.51 
25 min. 8.75 X 10 2 1.63 X 104 4.17 3.92 
30 min. 1.81 X 10 2 4.0 X 103 4.86 4.53 
45 min. 8.6 X 101 9.1 X 102 5.18 5.17 
60 min. 1.1 X 10° 2.06 X 102 6.07 6.11 
Picken^ in many experiments with their egg embryo propagated 608 atypical 
substrain found no evidence for a bi-phasic heat inactivation rate curve. 
The heat inactivation of the infective property studies indicate 
that the -S substrains are all more heat sensitive than the -R sub­
strains. A parallel relationship exists for the heat sensitivity of the 
infective and hemagglutinating properties of the -R and -S substrains of 
the same virus group. This relationship also exists for these two 
^Hofstad, M. S. and Picken, J. G., Jr., Ames, Iowa. A comparison 
of the effect of heat and ionizing radiation on viability and hemagglu­
tinating properties of several strains of Newcastle disease virus. 
Private communication. 1961. 
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Table 9. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat resistant substrain 982 
Time 
(minutes) 
Titer 
(PFU/ml) 
Exp. 1 Exp. 2 
Decrease in titer 
(Log10 PFU/ml) 
Exp. 1 Exp. 2 
Control 6.9 x 106 1.86 x 106 
5 min. 6.75 x 106 8.25 x 105 0.01 0.35 
10 min. 4.3 x 105 1.64 x 105 1.21 1.05 
20 min. 4.75 x 104 1.39 x 104 2.16 2.13 
30 min. 4.4 x 103 1.09 x 103 3.20 3.23 
45 min. 7.2 x 10 2 3.30 x 102 3.98 3.75 
60 min. 5.3 x 102 1.20 x 10 2 4.11 4.19 
90 min. 7.95 x 101 4.70 x 10L 4.94 4.60 
105 min. 4.2 x 101 9.00 x 10° 5.22 5.32 
120 min. 4.45 x 101 7.00 x 10° 5.19 5.42 
150 min. 1.3 x 101 6.00 x 10° 5.73 5.49 
180 min. 7.0 x 10° 5.00 x 10° 5.99 5.57 
properties of the 608 atypical-R. All of the heat inactivation curves 
of the infective property are bi-phasic, typical of animal viruses in 
general. 
From these results explanations analogous to those suggested for 
the hemagglutinating property can be used to explain the differences be­
tween the heat sensitivities of the infective property of the substrains 
studied. The specific structure(s) associated with the infective 
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Table 10. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat sensitive substrain 982 
Decrease in titer 
Time (PFU/ml) (Log10 PFU/ml) 
(minutes) Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 3.90 x 106 1.41 x 107 
5 min. 4.90 x 105 1.39 x 106 0.90 1.01 
10 min. 5.95 x 104 1.40 x 105 1.82 2.00 
15 min. 8.95 x 103 7.29 x 104 2.64 2.29 
20 min. 5.10 x 103 6.92 x 103 2.88 3.31 
25 min. 1.26 x 103 1.01 x 103 3.49 4.15 
30 min. 8.20 x 10 2 5.47 x 102 3.68 4.41 
45 min. 1.65 x 102 1.97 x 10 2 4.37 4.86 
60 min. 1.64 x 101 1.59 x 101 5.38 5.95 
property of the virus can be considered as being different in their heat 
sensitivities in the -R and -S substrains. If the infective properties 
are identical in structure(s) and heat sensitivity, then some other 
aspect of the virus must be more heat sensitive in the -S substrains 
and its response to heat interferes in some manner with the infective 
process. The parallel observed between the responses of the hemagglu-
tinating property and the infective property to the stress of heat is 
suggestive that the second explanation is the more logical. 
Hemolytic property Further information may be gained by studying 
the effect of heat upon the hemolytic property of the viruses. Data 
54 
Table 11. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat resistant substrain 608 atypical 
Time 
(minutes) Exp. 1 
Titer 
(PFU/ml) 
Exp. 2 
Decrease in titer 
(L°g10 PFU/ml) 
Exp. 1 Exp. 2 
Control 1.03 x 108 9.88 x 107 
10 min. 8.70 x 107 3.44 x 107 0.07 0.46 
20 min. 9.91 x 10 & 1.25 x 107 1.02 0.90 
30 min. 5.33 x 106 3.16 x 106 1.29 1.55 
45 min. 5.83 x 105 8.63 x 105 2.25 2.06 
60 min. 2.83 x 105 5.3 x 105 2.56 2.27 
80 min. 1.98 x 105 6.38 x 104 2.72 3.19 
100 min. 7.32 x 104 2.63 x 104 3.15 3.57 
120 min. 2.06 x 104 1.4 x 104 3.70 3.85 
140 min. 3.75 x 103 2.06 x 103 4.44 4.68 
180 min. 4.26 x 10 2 1.93 x 102 5.38 5.71 
typical of those presented in Table 12 were obtained when assaying the 
tissue culture virus substrains. These findings, characterized by-
negative or low activities, suggested a check on the hemolytic assay 
technique. The same procedure was used for a 174 HA heat resistant 
virus in allantoic fluid. The readings for this check experiment were 
much greater than those from the virus in tissue culture fluids. Since 
the original virus substrains had been shown to have the same 
thermostability of the hemagglutinin as the tissue culture propagated 
Fig. 5. Heat inactivation of the infective property of Newcastle 
disease virus. Comparison of duplicate experiments 
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Table 12. Hemolytic activity of Newcastle disease virus substrains 
Dilution of infected tissue culture fluid 
Virus substrains HAa 5 10 20 40 80 160 320 640 
174-R 1 100 0. 2b 0.18 0.18 0.1 0.05 0.02 0.01 0 
174-S 1 100 0.2 0.17 0.16 0.1 0 0 0 0 
GB-R 1 100 0 0 0 0 0 0 0 0 
GB-S 1 100 0.02 0 0 0 0 0 0 0 
982-R 1 100 0 0 0 0 0 0 0 0 
982-S 1 100 0.05 0.02 0 0 0 0 0 0 
608 atypical-R 1 100 0 0 0 0 0 0 0 0 
909 1 100 0 0 0 0 0 0 0 0 
H^emagglutination titer. 
^Optical density reading. 
substrains it was decided to carry out the hemolytic property phase of 
the work with the original egg embryo substrains. 
Previous studies indicated that the hemolytic activity was quickly 
destroyed at 56°C for many virus strains. A common temperature for heat 
inactivation studies was needed that would allow, if possible, for 
reasonable heat inactivation rates for all substrains. Therefore the 
initial study was made to establish the temperature at which a reasonable 
amount of the total hemolytic activity would be lost in a given time. 
For this preliminary study the virus substrains were prepared for 
hemolytic assay as indicated in the materials and methods section, 
brought to identical hemagglutination titers and then heated at 37, 42, 
47, 52 and 56°C for 15 minutes. Following heat stress the samples were 
serially diluted and assayed for hemolytic activity. Data obtained from 
this study are presented in Table 13. The data indicate that all sub­
strains are hemolytic and that the 56°C temperature is too high for 
definitive hemolytic assays. The 52°C temperature for 15 minutes gives 
measurable values and was chosen as the stress temperature for the next 
study. Hemolytic activity begins to fall off rapidly between 47 and 
52°C for all but two of the substrains tested. For GB HA heat sensitive 
it is between 42 and 47°C and for 608 atypical it is between 52 and 56°C. 
In the next experiment the viruses after proper preparation were heated 
at 52°C for 0, 10, 20 and 30 minutes, after which the hemolysin assay was 
run. The data are presented in Table 14. 
While the results are not sufficient to plot inactivation rate 
curves with any degree of certainty, they do provide sufficient data to 
establish the relative heat sensitivity patterns of the substrains. In 
each case the HA heat resistant substrain has a much more heat resistant 
hemolytic property than the HA heat sensitive substrain. The 608 
atypical substrain has by far the most heat resistant hemolytic property. 
The GB HA heat sensitive substrain exhibits the most heat sensitive 
hemolytic property of all substrains tested. The thermostability of the 
hemolytic property of the HA heat resistant and the HA heat sensitive 
substrains parallels that of the hemagglutinating property of the sub­
strains derived from these through tissue culture, i.e., the -R and -S 
substrains. Again the marked heat resistance of the 608 atypical 
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Table 13. Effect of temperature for 15 minutes on hemolytic property of 
Newcastle disease virus 
Virus 
substrains' Temp. HAL 
Virus dilution 
16 32 64 128 256 512 
174 HA 
resistant 
174 HA 
sensitive 
GB HA 
resistant 
GB HA 
sensitive 
Control 
37 
42 
47 
52 
56 
Control 
37 
42 
47 
52 
56 
Control 
37 
42 
47 
52 
56 
Control 
37 
42 
47 
52 
56 
1280 0. 69 0.69 0.67 0.5 0. ,3 0. ,21 0, .10 0, .02 
1280 0. ,69 0.68 0.61 0.49 0. ,28 0. ,17 0, .08 0, .02 
1280 0. ,68 0.66 0.60 0.46 0. 25 0. ,15 0. 07 0. 01 
1280 0. ,69 0.67 0.58 0.45 0. 23 0. 14 0. ,06 0. 01 
1280 0. ,51 0.46 0.37 0.21 0. 13 0. 08 0. ,03 0. ,0 
1280 0. 09 0.06 0.04 0.00 0. 00 0. 00 0. ,00 0. ,00 
1280 0. 70 0.68 0.61 0.52 0. 31 0. 24 0. ,13 0. ,04 
1280 0. 69 0.67 0.61 0.53 0. 31 0. 23 0. ,11 0. ,05 
1280 0. 69 0.67 0.61 0.52 0. 3 0. 22 0. 11 0. 05 
1280 0. 68 0.65 0.59 0.47 0. 28 0. 20 0. ,09 0. ,04 
640 0. 04 0.00 0.00 0.00 0. 00 0. 00 0. 00 0. ,00 
0 0. 00 0.00 0.00 0.00 0. 00 0. 00 0. 00 0. 00 
1280 0. 54 0.49 0.43 0.31 0. 18 0. 11 0. 07 0. 04 
1280 0. 55 0.50 0.44 0.33 0. 21 0. 14 0. 09 0. 05 
1280 0. 55 0.50 0.43 0.33 0. 21 0. 13 0. 09 0. 04 
1280 0. 54 0.48 0.42 0.30 0. 17 0. 11 0. 06 0. 03 
1280 0. 26 0.20 0.15 0.09 0. 05 0. 01 0. 00 0. 00 
1280 0. 08 0.05 0.1 0.00 0. 00 0. 00 0. 00 0. 00 
1280 0. 56 0.51 0.45 0.33 0. 20 0. 14 0. 09 0. 05 
1280 0. 56 0.51 0.44 0.32 0. 19 0. 12 0. 08 0. 04 
1280 0. 51 0.46 0.36 0.29 0. 21 0. 17 0. 09 0. 04 
1280 0. 45 0.37 0.31 0.24 0. 18 0. 11 0. 07 0. 03 
640 0. 01 0.00 0.00 0.00 0. 00 0. 00 0. 00 0. 00 
0 0. 00 0.00 0.00 0.00 0. 00 0. 00 0. 00 0. 00 
V^eterinary Medical Research Institute virus strains in allantoic 
fluid. 
'Hemagglutination. 
Table 13. (Continued) 
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Virus 
substrains3 Temp. HAC 
Virus dilution 
16 32 64 128 256 512 
982 HA 
resistant 
mtrol 1280 0.49 0.47 0.38 0. 31 0. 21 0. 12 0.08 0.03 
37 1280 0.49 0.45 0.36 0. 30 0. 22 0. 15 0.10 0.06 
42 1280 0.49 0.45 0.36 0. 30 0. 23 0. 15 0.09 0.05 
47 1280 0.48 0.43 0.35 0. 29 0. 21 0. 14 0.08 0.04 
52 1280 0.29 0.21 0.15 0. 09 0. 04 0. 01 0.00 0.00 
56 1280 0.19 0.17 0.07 0. 04 0. 01 0. 00 0.00 0.00 
982 HA 
sensitive 
Control 1280 0.47 0.39 0.32 0.24 0.18 0.11 0.06 0.02 
37 1280 0.47 0.39 0. 31 0. 22 0. 17 0.11 0.05 0.02 
42 1280 0.46 0.40 0. 32 0. 23 0. 18 0.12 0.07 0.03 
47 1280 0.44 0.39 0. 30 0. 22 0. 16 0.09 0.05 0.01 
52 640 0.20 0.15 0. 11 0. 03 0. 00 0.00 0.00 0.00 
56 0 0.00 0.00 0. 00 0. 00 0. 00 0.00 0.00 0.00 
Control 1280 0.51 0.49 0.45 0.38 0.30 0.21 0.12 0.06 
608 atypical-R 
37 1280 0.52 0.50 0.47 0.39 0.32 0. 25 0.16 0.09 
42 1280 0.51 0.49 0.44 0.37 0.30 0. 22 0.13 0.06 
47 1280 0.51 0.49 0.45 0.38 0.31 0. 21 0.13 0.06 
52 1280 0.51 0.49 0.44 0.38 0.30 0. 22 0.12 0.05 
56 1280 0.25 0.19 0.12 0.08 0.04 0. 01 0.00 0.00 
Control 1280 0.44 0.39 0.31 0.24 0.17 0.10 0.06 0.02 
909 
37 1280 0.44 0. 38 0.31 0.24 0. 16 0. 10 0.05 0.01 
42 1280 0.42 0. 37 0.30 0.23 0. 16 0. 09 0.05 0.01 
47 1280 0.40 0. 35 0.29 0.22 0. 15 0. 09 0.04 0.01 
52 640 0.23 0. 17 0.12 0.08 0. 05 0. 02 0.00 0.00 
56 0 0.00 0. 00 0.00 0.00 0. 00 0. 00 0.00 0.00 
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Table 13. (Continued) 
Virus Virus dilution 
substrains3 Temp. °C HA" 4 8 16 32 64 128 256 512 
Control 1280 0.50 0.47 0.43 0.35 0.29 0.20 0.12 0.05 
608 HA 
resistant 37 1280 0.50 0.47 0.43 0.36 0.29 0.19 0.11 0.06 
42 1280 0.49 0.48 0.41 0.34 0.28 0.19 0.11 0.05 
47 1280 0.49 0.47 0.42 0.34 0.28 0.18 0.10 0.04 
52 1280 0.35 0.29 0.22 0.17 0.10 0.06 0.02 0.00 
56 1280 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Control 1280 0.49 0.43 0.36 0.28 0.21 0.14 0.08 0.03 
608 HA 
sensitive 37 1280 0.49 0.42 0.35 0.28 0.21 0.14 0.08 0.03 
42 1280 0.50 0.44 0.36 0.29 0.20 0.11 0.06 0.02 
47 1280 0.49 0.41 0.34 0.27 0.19 0.10 0.05 0.01 
52 640 0.17 0.12 0.05 0.01 0.00 0.00 0.00 0.00 
56 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
substrains is noted as well as the greater heat sensitivity of the GB-S 
and the GB HA heat sensitive substrains. Again, from these results 
explanations, analogous in this case to those suggested for both the 
hemagglutinating and infective properties, can be used to explain the 
difference between the heat sensitivity of the hemolytic property of the 
substrain studied. 
Radiation stress of virus properties 
The virus substrains were subjected to gamma radiation from a Co^ ° 
source to determine its inactivating effect on the several properties of 
the various Newcastle disease virus substrains. The radiation 
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Table 14. Effect of 52°C on hemolytic property of Newcastle disease 
virus 
Virus Time Dilutions 
substrains3 (minutes) 4 8 16 32 64 128 256 512 
174 HA 0 0.67 0.60 0.51 0.39 0.3 0.19 0.11 0.05 
resistant 10 0.55 0.47 0.40 0.33 0.24 0.15 0.09 0.04 
20 0.34 0.25 0.17 0.12 0.08 0.04 0.01 0 
30 0.03 0 0 0 0 0 0 0 
174 HA 0 0.69 0.62 0.55 0.51 0.35 0.26 0.15 0.09 
sensitive 10 0.24 0.17 0.12 0.09 0.04 0.01 0 0 
20 0.09 0.05 0.03 0 0 0 0 0 
30 0 0 0 0 0 0 0 0 
GB HA 0 0.50 0.45 0.39 0.31 0.25 0.18 0.11 0.05 
resistant 10 0.44 0.37 0.30 0.24 0.18 0.10 0.05 0.02 
20 0.21 0.16 0.12 0.07 0.04 0.01 0 0 
30 0.08 0.02 0 0 0 0 0 0 
GB HA 0 0.53 0.49 0.43 0.38 0.31 0.25 0.16 0.09 
sensitive 10 0.16 0.11 0.07 0.04 0.01 0 0 0 
20 0.07 0.04 0.02 0.01 0 0 0 0 
30 0 0 0 0 0 0 0 0 
982 HA 0 0.49 0.46 0.38 0.30 0.21 0.14 0.09 0.05 
resistant 10 0.30 0.24 0.19 0.11 0.07 0.04 0.01 0 
20 0.21 0.16 0.12 0.09 0.05 0.02 0 0 
30 0.11 0.08 0.04 0.02 0 0 0 0 
982 HA 0 0.45 0.40 0.34 0.29 0.21 0.16 0.09 0.04 
sensitive 10 0.25 0.19 0.13 0.09 0.05 0.02 0.01 0 
20 0.09 0.06 0.03 0 0 0 0 0 
30 0 0 0 0 0 0 0 0 
608 atypical-R 0 0.50 0.46 0.41 0.35 0.29 0.21 0.17 0.10 
10 0.49 0.45 0.41 0.34 0.28 0.20 0.15 0.09 
20 0.47 0.42 0.39 0.32 0.26 0.19 0.14 0.08 
30 0.44 0.40 0.36 0.30 0.25 0.18 0.12 0.07 
909 0 0.41 0.37 0.30 0.22 0.17 0.12 0.08 0.05 
10 0.31 0.26 0.21 0.16 0.11 0.07 0.04 0.01 
20 0.11 0.09 0.05 0.03 0.01 0 0 0 
30 0 0 0 0 0 0 0 0 
^Veterinary Medical Research Institute virus substrains in 
allantoic fluid. 
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Table 14. (Continued) 
Virus Time Dilutions 
substrains3 (minutes) 4 8 16 32 64 128 256 512 
608 HA 0 0.46 0.40 0.34 0.29 0.21 0.17 0.12 0.09 
resistant 10 0.28 0.22 0.17 0.13 0.09 0.05 0.03 0.01 
' 20 0.13 0.09 0.06 0.04 0.01 0 0 0 
30 0 0 0 0 0 0 0 0 
608 HA 0 0.42 0.38 0.31 0.27 0.20 0.14 0.09 0.05 
sensitive 10 0.16 0.11 0.08 0.05 0.02 0.01 0 0 
20 0.07 0.04 0 0 0 0 0 0 
30 0 0 0 0 0 0 0 0 
experiments were carried out in such a manner that differences or 
similarities observed could be interpreted by the target theory philoso­
phy of analysis. 
The three conditions that must be fulfilled by the experiment in 
order to apply the target theory to the results are: (1) The survival 
curve of the irradiated virus is exponential with the radiation dose, 
i.e., a single hit curve. (2) The effect of a given dose is independent 
of the intensity at which the dose is given. (3) The same degree of 
effect is produced by increased radiation doses as one proceeds from gamma 
rays through soft X-rays to alpha particles. 
Previous studies by Hofstad and Picken^ established that the first 
two criteria are met if Newcastle disease virus preparations are 
H^ofstad, M. S. and Picken, J. C., Jr., Ames, Iowa. A comparison of 
the effect of heat and ionizing radiation on viability and hemagglutinat-
ing properties of several strains of Newcastle disease virus. Private 
communication. 1961. 
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irradiated in the frozen state at liquid nitrogen temperatures (-196°C). 
Other workers (131, 134) have demonstrated that the third criteria is 
fulfilled for Newcastle disease virus under similar experimental condi­
tions. 
Hemagglutinating property The irradiation procedures were 
described in the materials and methods section. The effects of gamma 
radiation on the hemagglutinating property of Newcastle disease virus 
substrains are presented in Table 15. 
The hemagglutination titers are given for the unexposed control and 
after exposure to the dosages indicated. It is quite obvious that the 
dosages that were applied were not adequate to materially decrease the 
titers of the irradiated viruses from those of the unexposed controls. 
There is a slight decrease in titers of the GB-S and 982-S substrains at 
the highest dosage level. It was not possible to extend this study to 
higher dosage levels due to the fact that the irradiation facility was 
not available for the extended periods of time that would have been re­
quired to administer the dosages required, i.e., 39.9 x 10^ rads required 
48 hours in the facility. No conclusions can be drawn from these 
limited data other than they do suggest the dosage level at which 
measurable decreases in hemagglutination titers can be expected. 
Infectivity property The plaque technique was used to assay the 
decrease in number of infective particles following gamma radiation. 
The data obtained for the three paired substrains and the 608 atypical-R 
substrain are presented in Tables 16 through 22 in a manner similar to 
that used for presentation of the heat inactivation of the infected 
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Table 15. Effects of gamma (Co ®^) radiation on hemagglutinin of 
Newcastle disease virus substrains 
Virus substrain 
Dose in rads x 106 
0 9.97 14.96 19.9 24.93 29.9 39.9 
174-R 160a 160 160 160 160 160 
174-S 160 160 160 160 160 
GB-R 160 160 - - - 160 160 160 
GB-S 160 160 160 160 100 
982-R 160 160 160 160 160 160 
982-S 160 160 - - - 160 160 100 
608 atypical-R 160 160 160 160 160 160 
^Readings of hemagglutination titers. 
Table 16. Inactivation with gamma radiation (Co^O) of infectivity of 
Newcastle disease virus. Heat resistant substrain 174 
Dose Titer Decrease in titer 
(rads x 105) (PFU/ml) (L°glO PFP/nl) 
Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 2.50 x 105 5.99 x 107 
8.45 6.00 x 103 4.14 x 106 1.62 1.16 
16.90 1.30 x 103 2.31 x 105 2.28 2.41 
25.34 1.09 x 10 2 2.01 x 104 3.36 3.47 
33.79 1.15 x 101 9.36 x 102 4.34 4.81 
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Table 17. Inactivation with gamma radiation (Co^) of infectivity of 
Newcastle disease virus. Heat sensitive substrain 174 
Decrease in titer 
Dose (PFU/ml) (Log10 PFU/ml) 
(rads x 10^ ) Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 1.32 x 107 3.63 x 107 
8.45 5.80 x 105 2.48 x 106 1.36 1.17 
16.90 3.00 x 104 2.67 x 105 2.64 2.13 
25.34 1.07 x 103 4.16 x 104 4.09 2.94 
33.79 6.58 x 101 8.31 x 102 5.30 4.64 
Table 18. Inactivation with gamma radiation (Co^) of infectivity of 
Newcastle disease virus. Heat resistant substrain GB 
. Decrease in titer 
Dose (PFP/mU (Log10 CT/ml) 
(rads x 10~*) Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 2.26 x 107 6.40 x ÎO7 
8.41 2.79 x 106 6.90 x 106 0.91 0.97 
16.82 4.39 x 105 9.45 x 105 1.71 1.83 
25.24 8.05 x 103 4.85 x 104 3.45 3.12 
33.65 3.20 x 102 3.80 x 103 4.85 4.23 
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Table 19. Inactivation with gamma radiation (Co^ O) of infectivity of 
Newcastle disease virus. Heat sensitive substrain GB 
Dose 
(rads x 10 ) 
Titer 
(PFU/ml) 
Decrease 
(Log10 
in titer 
PFU/ml) 
Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 6.20 x 106 1.39 x 107 
8.41 1.90 x 105 1.04 x 106 1.51 1.13 
16.82 3.00 x 104 4.00 x 104 2.32 2.54 
25.24 1.91 x 103 3.33 x 103 3.51 3.62 
33.65 7.13 x 101 2.31 x 103 4.94 3.78 
Table 20. Inactivation with gamma radiation (Co^ ®) of infectivity of 
Newcastle disease virus. Heat resistant substrain 982 
Decrease in titer 
fSc/mn (L,g10 PFU/ml) 
(rads x 10 ) Exp. 1 Exp. 2 Exp. 1 Exp. : 
Control 7.05 x 106 1.03 x 10* 
8.43 6.55 x 105 8.65 x 104 1.03 1.08 
16.86 2.80 x io4 7.15 x 103 2.40 2.16 
25.29 9.00 x 10 2 5.25 x 102 3.89 3.29 
33.72 6.17 x 101 6.58 x 101 5.06 4.19 
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Table 21. Inactivation with gamma radiation (Co^) of infectivity of 
Newcastle disease virus. Heat sensitive substrain 982 
Decrease in titer 
Dose „ (PFU/ml) L^og10 PFU/ml) 
O V 1 Vvt. 1 T7<rr> 9 T7 1 17 (rads x 10 ) Exp. 1 Exp. 2 Exp. 1 Exp. 
Control 8.15 x 105 7.00 x 105 
8.43 8.50 x 104 1.50 x 105 0.98 0.67 
16.86 5.90 x 103 1.10 x 104 2.14 1.80 
25.29 1.77 x 102 1.50 x 103 3.66 2.67 
33.72 6.50 x 10° 3.75 x 101 5.10 4.27 
Table 22. Inactivation with gamma radiation (Co ) of infectivity of 
Newcastle disease virus. Heat resistant substrain 608 
atypical 
Decrease in titer 
Dose . (PFU/ml) (Log^ PFU/ml) 
(rads x 10 ) Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 1.97 x 107 1.22 x 107 
8.34 1.60 x 106 1.29 x 106 1.10 0.98 
16.68 7.25 x 104 5.70 x 105 2.43 1.33 
25.02 2.65 x 103 1.19 x 104 3.87 3.01 
33.36 6.25 x 101 6.58 x 101 5.50 5.27 
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property. The results of the paired experiments are in agreement within 
limitations of the assay procedure. 
Representative data from the tables are presented in graphic form 
in Figs. 11 through 15. Fig. 11 presents the comparison of the 
inactivation rate curves for the 174-R and 174-S substrains. The 
exponential survival curves are evident and the slopes of these curves 
are in essential agreement. Figs. 12 and 13 present the data for the 
GB and 982 paired substrains respectively. Again the essential natures 
of exponential survival curves are evident and the similarities between 
the slopes of the heat sensitive and heat resistant groups can be 
observed. 
Data for the 174-R, GB-R, 982-R and the 608 atypical-R substrains 
are presented in Fig. 15. The essential similarity in slopes repre­
senting the radiation induced inactivation rates is evident. Data for 
the heat sensitive substrains, though not plotted, show this same 
essential agreement. 
The important fact coming from this series of experiments is that 
the gamma radiation inactivation rates obtained for the infective 
property of Newcastle disease virus substrains are in the same order of 
magnitude for all of the substrains studied. 
Using the target theory of interpretation, identical slopes of 
inactivation rate curves mean that the radiation sensitive volumes of 
the properties being inactivated are identical in size. Thus with the 
virus substrains studied the infective properties occupy similar radia­
tion sensitive volumes. 
Fig. 11. Radiation inactivation (Go^®) of the infective property of 
Newcastle disease virus. Comparison of heat resistant and 
heat sensitive substrains 
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Fig. 12. Radiation inactivation (Co ) of the infective property of 
Newcastle disease virus. Comparison of heat resistant and 
heat sensitive substrains 
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Fig. 13. Radiation inactivation (Co^O) of the infective property of 
Newcastle disease virus. Comparison of heat resistant and 
heat sensitive substrains 
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Fig. 14. Radiation inactivation (Co^®) of the infective property of 
Newcastle disease virus 
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Fig. 15. Radiation inactivation (Co ) of the infective property of 
Newcastle disease virus. Comparison of four heat resistant 
substrains 
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Although these similarities exist they do not indicate that identi­
cal structures occupy the areas, but only that they might be identical. 
Hemolytic property An attempt was made to investigate the 
radiation inactivation of the hemolytic property of the Newcastle 
disease virus substrains derived from tissue culture. Samples were ir­
radiated and the hemolytic activity of the irradiated preparation was 
assayed. The results obtained were similar to those for the thermosta­
bility study of the hemolytic property with the tissue culture derived 
substrains, in that insufficient virus was present to demonstrate 
activity. It was not possible to initiate an additional series of 
experiments with the original embryo propagated substrains because of 
the unavailability in the irradiation facility. 
Neutralization and evaluation of gamma radiation survivors 
An attempt was made through the application of neutralization and heat 
stress procedures to determine if virus populations resulting from 
individual viruses surviving radiation differed from the original popula­
tions with respect to heat sensitivity. The opportunity to conduct this 
phase was presented by the work conducted in the previous section. 
Plaques that appeared on the plates used to evaluate the effect of the 
higher dosages of radiation provided the potential isolates for this 
study. 
The individual virus particles from which the plaques originated 
could have been either unaffected or grossly influenced by the radiation 
stress in the following ways: (1) The virus particle was not stressed, 
allowing it to multiply in an appropriate system and produce a population 
characteristic of the original. (2) The virus particle was affected but 
not to the extent that its power to multiply was lost. Depending upon 
the structures altered in or on the virus particle, it would produce a 
population characteristic of the original or because of a change in the 
"genetic code" it would produce a population different in some respect 
from the original. (3) It was also possible that the original popula­
tion was not homogeneous and some individuals might conceivably be more 
resistant to the more subtle effects of the radiation stress. These 
individuals would result in a new population with radiation resistant 
characteristics either by virtue of their not being stressed or being 
insufficiently stressed to be inactivated. 
It was considered that the survivors appearing as plaques following 
the higher doses of gamma radiation in the radiation inactivation 
infectivity studies might represent one or more of the possibilities 
suggested in the previous paragraph. 
In theory, the neutralization of a virus particle by its anti-
genically related antibodies in an antiserum should render the particles 
incapable of infectivity. Virus particles unrelated antigenically to the 
antibodies of the antiserum would not be neutralized and would be capable 
of multiplication in an appropriate system. When applied to virus popu­
lations propagated from gamma radiation survivors, the proper proportions 
of virus and homologous antiserum should neutralize the following 
individual viruses: (1) unstressed, (2) stressed but not altered and (3) 
"genetic code" stressed but grossly antigenically unchanged. The viruses 
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that should escape neutralization would include (1) any antigenically 
unrelated viruses in the population and (2) "genetic code" stressed suf­
ficiently to alter gross antigenicity. By using in addition heterologous 
but related antisera it was considered possible that some additional 
subtile differences in antigenic characteristics might be detected. 
After appropriate plaque counts were obtained for the radiation 
stress studies, the plates representing the samples that had received 
the higher radiation dosages were examined for evidence of differences 
in plaque morphology. No differences other than normal variations with 
respect to plaque size were observed. From 15 to 20 well isolated 
plaques were picked for each of the seven substrains, allowed to multiply 
in a liquid medium tissue culture system, and the hemagglutination titers 
were determined to establish the relative amount of virus present. 
Representative populations from each substrain were neutralized 
with both hemologous and heterologous antisera in a variety of virus-
antiserum concentrations. After neutralization, tissue culture 
monolayers were infected with 0.2 ml of the various virus-antiserum 
mixtures. After proper incubation the plates were examined for plaque 
formation. 
The virus particles escaping neutralization as indicated by the 
appearance of plaques in the chicken embryo fibroblast system were 
considered as potential variants from the original population. Ten 
plaques were harvested for each virus substrain-antiserum combination. 
The plaque isolates were grown up in liquid medium and checked for 
hemagglutination heat sensitivity at 56°C for 15 and 60 minutes at a 
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1:100 dilution. The 150 isolates derived from the original three heat 
sensitive substrains had no demonstrable hemagglutinating activity after 
15 minutes at 56°C. The 200 isolates derived from the four heat 
resistant substrains retained their hemagglutinating activity after 60 
minutes at 56°C. These results indicated no marked departure in heat 
sensitivity of this property from the original substrains. 
Since no differences were observable between the 10 isolates from 
each virus antiserum combination, one was picked at random and evaluated 
for the heat sensitivity of its infective property. The results of these 
studies are presented in Tables 23 through 57. Though not presented 
graphically, these data with the exception of that for the 174-R virus 
substrain -- 982 antiserum combination, Table 25, show good correlation 
with the data obtained for the original substrains presented for the heat 
stress of the infective property in a preceding section. Graphic evalua­
tion of the data for the isolate resulting from the 174-R substrain --
982 antiserum combination indicates that it is generally more resistant 
to heat stress than the original 174-R substrain and its heat inactiva­
tion rate curve differs also in that it is only slightly two-phasic in 
nature. 
During the inactivation of infectivity of GB-R substrain at 56°C, 
an isolated plaque was observed at a time which no other virus particle 
had produced plaques. The plaque was harvested and identified as GB-R 
substrain (isolate after heat). A virus population was produced from the 
plaque for heat inactivation of the infective and hemagglutinating 
properties. The results of the test are presented in Table 58. 
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Table 23. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat resistant substrain 
surviving treatment with gamma radiation followed 
by treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Lo§io PFU/ml) 
Control 3.39 x 107 
30 min. 1.24 x 105 2.44 
60 min. 1.14 x 104 3.47 
90 min. 3.84 x 103 3.95 
120 min. 4.41 x 10 2 4.89 
150 min. 1.91 x 102 5.25 
180 min. 7.02 x 
t—f o
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1 
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Table 24. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat resistant substrain 
surviving treatment with gamma radiation followed 
by treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 3.39 x 107 
30 min. 1.31 x 105 2.41 
60 min. 1.16 x 104 3.47 
90 min. 3.72 x 103 3.96 
120 min. 4.56 x 102 4.87 
150 min. 2.87 x 102 5.07 
180 min. 5.06 x 101 5.83 
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Table 25. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat resistant substrain 
surviving treatment with gamma radiation followed 
by treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 3.39 x 107 
30 min. 4.29 x 106 0.89 
60 min. 1.07 x 106 1.50 
90 min. 5.50 x 105 1.79 
120 min. 5.31 x 104 2.81 
150 min. 3.78 x 103 3.95 
180 min. 9.34 x 102 4.56 
Table 26. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat resistant substrain 
surviving treatment with gamma radiation followed 
by treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Lo§l0 PFU/ml) 
Control 3.39 x 107 
30 min. 2.06 x 105 2.22 
60 min. 2.11 x 104 3.21 
90 min. 3.76 x 103 3.96 
120 min. 4.38 x 102 4.89 
150 min. 1.57 x 102 5.33 
180 min. 6.97 x 101 5.69 
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Table 27. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat resistant substrain 
surviving treatment with gamma radiation followed 
by treatment with antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Logl0 PFU/ml) 
Control 3.39 x 107 
30 min. 1.98 x 105 2.23 
60 min. 1.35 x 104 3.40 
90 min. 3.46 x 103 3.99 
120 min. 4.16 x 102 4.91 
150 min. 3.09 x 102 5.04 
180 min. 6.54 x 101 5.72 
Table 28. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat sensitive substrain 
surviving treatment with gamma radiation followed 
by treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes (PFU/ml) (Log^g PFU/ml) 
Control 7.01 x 107 
15 min. 5.04 x 105 2.14 
30 min. 4.01 x 104 3.24 
45 min. 9.97 x 103 3.85 
60 min. 8.31 x 10 2 4.93 
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Table 29. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat sensitive substrain 
surviving treatment with gamma radiation followed 
by treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 7.01 x 107 
15 min. 9.88 x 105 1.85 
30 min. 4.27 x 104 3.21 
45 min. 8.89 x 103 3.90 
60 min. 8.62 x 102 4.91 
Table 30. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat sensitive substrain 
surviving treatment with gamma radiation followed 
by treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 7.01 x 107 
15 min. 4.32 x 106 1.21 
30 min. 5.49 x 105 2.11 
45 min. 7.19 x 104 2.99 
60 min. 5.91 x 103 4.07 
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Table 31. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat sensitive substrain 
surviving treatment with gamma radiation followed 
by treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 7.01 x 107 
15 min. 8.34 x 105 1.93 
30 min. 4.31 x 104 3.21 
45 min. 8.24 x 103 3.93 
60 min. 8.57 x 10 2 4.91 
Table 32. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 174 heat sensitive substrain 
surviving treatment with gamma radiation followed 
by treatment with antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 7.01 x 107 
15 lin. 7.19 x 105 1.99 
30 min. 4.97 x 104 3.15 
45 min. 8.76 x 103 3.90 
60 min. 7.99 x 
CM O
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Table 33. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 9.18 x 107 
30 min. 5.14 x 106 1.25 
60 min. 6.39 x 104 3.16 
90 min. 5.32 x 103 4.24 
120 min. 4.96 x 103 4.27 
150 min. 4.47 x 10 2 5.31 
180 min. 1.33 x 10 2 5.84 
Table 34. Inactivation at 56*C of infectivity of Newcastle 
disease virus. GB heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 9.18 x 107 
30 rain. 4.17 x 106 1.34 
60 min. 5.86 x 104 3.20 
90 min. 9.67 x 10 2 4.98 
120 min. 6.53 x 10 2 5.15 
150 min. 2.95 x 10 2 5.49 
180 min. 1.45 x 102 5.80 
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Table 35. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 9.18 x 107 
30 min. 5.21 x 106 1.25 
60 min. 6.43 x 104 3.15 
90 min. 5.27 x 103 4.23 
120 min. 5.01 x 10 3 4.26 
150 min. 4.45 x 10 2 5.31 
180 min. 1.41 x 10 2 5.81 
Table 36. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 9.18 x 107 
30 min. 5.02 x 106 1.26 
60 min. 6.10 x 104 3.18 
90 min. 5.07 x 103 4.26 
120 min. 4.99 x 103 4.27 
150 min. 6.17 x 102 5.17 
180 min. 2.64 x 102 5.54 
101 
Table 37. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with B^ antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 9.18 x 107 
30 min. 5.10 x 106 1.25 
60 min. 5.89 x 104 3.19 
90 min. 6.04 x 103 4.18 
120 min. 5.00 x 103 4.26 
150 min. 3.26 x 102 5.45 
180 min. 1.19 x 10 2 5.89 
Table 38. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat sensitive substrain sur­
viving treatment with gamma radiation followed 
by treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 8.57 x 107 
15 min. 1.22 x 105 2.86 
30 min. 4.76 x 102 5.26 
45 min. 1.28 x 10 2 5.83 
60 min. 3.49 x 101 6.39 
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Table 39. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat sensitive substrain sur­
viving treatment with gamma radiation followed 
by treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log10 pFU/ml) 
Control 8.57 x 107 
15 min. 1.34 x 105 2.81 
30 min. 3.18 x 102 5.43 
45 min. 1.59 x 10 2 5.73 
60 min. 4.18 x 101 6.31 
Table 40. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat sensitive substrain sur­
viving treatment with gamma radiation followed 
by treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log10 PFtj/ml) 
Control 8.57 x 107 
15 min. 1.29 x 105 2.82 
30 min. 3.72 x 102 5.36 
45 min. 1.41 x 102 5.78 
60 min. 3.97 x 101 6.33 
103 
Table 41. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat sensitive substrain sur­
viving treatment with gamma radiation followed 
by treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 8.57 x 107 
15 min. 1.19 x 105 2.86 
30 min. 3.29 x 102 5.42 
45 min. 2.01 x 102 5.63 
60 min. 4.23 x 101 6.31 
Table 42. Inactivation at 56°C of infectivity of Newcastle 
disease virus. GB heat sensitive substrain sur­
viving treatment with gamma radiation followed 
by treatment with B% antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 8.57 x 107 
15 min. 1.07 x 105 2.90 
30 min. 3.54 x 102 5.38 
45 min. 1.65 x 102 5.72 
60 min. 3.56 x 101 6.38 
104 
Table 43. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log10 PFU/ml) 
Control 4.05 x 106 
30 min. 9.71 x 103 2.62 
60 min. 1.02 x 10 2 4.60 
90 min. 5.14 x 10L 4.90 
120 min. 4.01 x 101 5.00 
150 min. 1.19 x 101 5.53 
180 min. 6.31 x 10° 5.81 
Table 44. Inactivation at 56eC of infectivity of Newcastle 
disease virus. 982 heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 4.05 x 106 
30 min. 8.57 x 103 2.67 
60 min. 1.09 x 102 3.57 
90 min. 6.27 x 101 4.81 
120 min. 4.18 x 101 4.99 
150 min. 1.15 x 101 5.55 
180 min. 7.56 x 10° 5.73 
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Table 45. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 4.05 x 106 
30 min. 7.06 x 104 1.76 
60 min. 7.32 x 103 2.74 
90 min. 9.76 x 102 3.62 
120 min. 6.14 x 102 3.82 
150 min. 7.91 x 101 4.71 
180 min. 6.15 x 10° 5.82 
Table 46. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat resistant substrain sur­
viving treatment with gamma radiation followed 
by treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 4.05 x 10 6 
30 min. 8.81 x 103 2.66 
60 min. 3.82 x 102 4.03 
90 min. 7.36 x 101 4.74 
120 min. 6.95 x 101 4.76 
150 min. 9.82 x 
o
 o
 
« —
i 
5.62 
180 min. 5.17 x m
 
o
 o
 
5.89 
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Table 47. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat resistant substrain sur­
viving treatment with gamma radiation followed by 
treatment with antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^Q PFU/ml) 
Control 4.05 x 106 
30 min. 1.09 x 104 2.57 
60 min. 3.16 x 103 3.11 
90 min. 1.01 x 103 3.60 
120 min. 1.15 x 102 4.55 
150 min. 7.31 x 101 4.74 
180 min. 6.28 x 10° 5.81 
Table 48. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat sensitive substrain sur­
viving treatment with gamma radiation followed by 
treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log-^g PFU/ml) 
Control 2.06 x 107 
15 min. 6.17 x 104 2.52 
30 min. 9.36 x 102 4.34 
45 min. 8.41 x 101 5.39 
60 min. 1.14 x 101 6.26 
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Table 49. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat sensitive substrain sur­
viving treatment with gamma radiation followed by 
treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 2.06 x 107 
15 min. 5.39 x 104 2.58 
30 min. 8.76 x 102 4.37 
45 min. 2.07 x 102 5.00 
60 min. 4.13 x 101 5.70 
Table 50. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat sensitive substrain sur­
viving treatment with gamma radiation followed by 
treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log-^Q PFU/ml) 
Control 2.06 x 107 
15 min. 7.87 x 105 1.42 
30 min. 6.66 x 
%
 
i—l 
2.49 
45 min. 7.96 x 102 4.41 
60 min. 4.18 x 102 4.69 
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Table 51. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat sensitive substrain sur­
viving treatment with gamma radiation followed by 
treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 2.06 x 107 
15 min. 7.03 x 104 2.47 
30 min. 8.52 x 102 4.38 
45 min. 8.69 x 101 5.38 
60 min. 2.34 x IO1 5.94 
Table 52. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 982 heat sensitive substrain sur­
viving treatment with gamma radiation followed by 
treatment with B^ antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^g PFU/ml) 
Control 2.06 x 107 
15 min. 7.14 x 104 2.46 
30 min. 7.99 x 102 4.41 
45 min. 8.54 x 101 5.38 
60 min. 2.02 x 101 6.01 
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Table 53. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 608 atypical heat resistant sub­
strain surviving treatment with gamma radiation 
followed by treatment with 174 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log1Q PFU/ml) 
Control 8.56 x 107 
30 min. 4.39 x 106 1.29 
60 min. 4.97 x 105 2.24 
90 min. 4.15 x 104 3.31 
120 miii. 1.14 x 104 3.88 
150 min. 2.16 x 103 4.60 
180 min. 1.86 x 10 2 5.66 
Table 54. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 608 atypical heat resistant sub­
strain surviving treatment with gamma radiation 
followed by treatment with GB antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 8.56 x 107 
30 min. 4.81 x 10 6 1.25 
60 min. 5.14 x 105 2.21 
90 min. 3.51 x 104 3.39 
120 min. 2.61 x 104 3.52 
150 min. 4.56 x 103 4.27 
180 min. 2.67 x 10 2 5.51 
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Table 55. Inactivation at 56°C of infectivity of Newcastle 
disease virus. 608 atypical heat resistant sub­
strain surviving treatment with gamma radiation 
followed by treatment with 982 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (LoSio PFU/ml) 
Control 8.56 x 107 
30 min. 4.72 x 106 1.26 
60 min. 4.74 x 105 2.26 
90 min. 3.42 x 104 3.40 
120 min. 9.92 x 103 3.94 
150 min. 1. 63 x 103 4.72 
180 min. 3.10 x 10 2 5.44 
Table 56. Inactivation of 56°C of infectivity of Newcastle 
disease virus. 608 atypical heat resistant sub­
strain surviving treatment with gamma radiation 
followed by treatment with 608 antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (Log^ PFU/ml) 
Control 8.56 x 107 
30 min. 4.75 x 106 1.26 
60 min. 5.06 x 105 2.23 
90 min. 3.59 x 
i—i 
3.78 
120 min. 1.02 x 104 3.92 
150 min. 2.17 x 103 4.60 
180 min. 4.92 x 102 5.24 
Ill 
Table 57. Inactivation at 56°C of infectivity of Newcastle disease 
virus, 608 atypical heat resistant substrain surviving 
treatment with gamma radiation followed by treatment with 
antiserum 
Time Titer Decrease in titer 
(minutes) (PFU/ml) (LoSiq PFU/ml) 
Control 8.56 x 107 
30 min. 4.79 x 106 1.25 
60 min. 5.13 x 105 2.22 
90 min. 3.74 x 104 3.36 
120 min. 1.49 x 104 3.76 
150 min. 2.63 x 103 4.51 
180 min. 2.71 x 10 2 5.50 
In Fig. 16 are the curves of the duplicate experiments for this 
isolate. There is little tendency for the bi-phasic curve and greater 
resistance is noted for the population than in the original GB-R sub­
strain. 
The heat stress of the hemagglutinating property indicated that 
the titer of the control was 1:160, the same as for the parent strain. 
This titer is present after 90 minutes, 1:80 at 105 minutes and all 
activity is lost after 120 minutes at 56°C. This is slightly more 
resistant than the original population. 
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Table 58. Inactivation at 56°C of infectivity of Newcastle disease 
virus. Heat resistant (from heat) substrain GB 
lime liter 
(minutes) (PFU/ml) L^og10 ^ ^ 
Exp. 1 Exp. 2 Exp. 1 Exp. 2 
Control 5.70 x 107 1.20 x 107 
10 min. 1.50 x 107 8.00 x 106 0.58 0.18 
20 min. 1.02 x 107 6.10 x 106 0.75 0.29 
30 min. 7.50 x 106 3.80 x 106 0.88 0.50 
45 min. 6.20 x 106 6.70 x 105 0.96 1.25 
60 min. 2.82 x 106 5.30 x 105 1.31 1.35 
75 min. 8.15 x 105 1.89 x 105 1.84 1.80 
90 min. 6.90 x 105 6.00 x 104 1.92 2.30 
105 min. 3.50 x 105 9.75 x 103 2.21 3.09 
120 min. 1.42 x 105 5.55 x 103 2.60 3.33 
150 min. 1.77 x 104 1.00 x 103 3.51 4.08 
180 min. 1.35 x 103 6.50 x 101 4.63 5.27 
Fig. 16. Heat inactivation of the infective property of Newcastle 
disease virus. Comparison of duplicate experiments 
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DISCUSSION 
Newcastle disease virus was selected for study because it had 
biologic and serologic properties that could be evaluated accurately and 
several pairs of laboratory substrains were available that differed 
markedly in the stability of their hemagglutinating property to the 
stress of heat. The difference in thermostability of this property 
suggested that the viruses composing the populations of these paired 
substrains must be different in some aspect of their structure. Expan­
sion of the thermostability studies to the infective and hemolytic 
properties of the viruses was undertaken to establish if some definite 
relationship between the thermostabilities of these three properties 
could be observed. 
A homogeneous virus population was essential and the serial passage 
in tissue culture seemed to offer the best way of preparing the popula­
tion. To establish homogeneity in the virus population three serial 
passages in tissue culture, each from a single plaque isolate, were 
made. 
Considerable variation was noted in plaque size with small, medium 
and large plaques being observed in the first passage for all of the 
substrains. The percentage of large plaques decreased with each subse­
quent passage of the medium and large plaque isolates. No large plaques 
resulted from the passage of small plaque isolates. 
Studies were undertaken to compare the responses of the tissue 
culture propagated substrains derived from the small, medium and large 
plaques with the original chicken embryo substrains and the results 
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indicated that the heat sensitivity characteristics of the hemagglutinat­
ing properties of the original substrains were carried over to the 
tissue culture substrains. The hemagglutination titers did not differ 
for the viruses derived from the various sized plaques, nor did the 
plaque size appear to influence the thermostability of the hemagglutinin 
of a substrain. The small plaques obtained from the third passage of 
each substrain were used for propagation of virus for the remaining 
studies because of the apparent greater homogeneity, based on plaque 
size, in the virus population derived from small plaques. 
Studies were undertaken to establish the degree of heat sensitivity 
of the hemagglutinating property of each substrain. After stress at 
56°C, the Newcastle disease virus substrains were designated as either 
heat sensitive or heat resistant. The heat sensitive group did not 
cause hemagglutination of red blood cells after heating for 10 minutes 
at 56°C, while the heat resistant substrains were all fully active after 
60 minutes exposure. Variation was observed among the resistant sub­
strains after stress for longer periods of time. The GB-R was the most 
sensitive of the resistant group while the 608 atypical-R was the most 
stabile. This variation in thermostability of the hemagglutinating 
property is in agreement with the results reached by other workers using 
Newcastle disease virus isolates. These data enabled the formation of 
a hypothesis for interpretation of the structural implications 
responsible for the differences observed in the heat sensitivities. 
Two additional viral properties, the infective property and the 
hemolytic property, were studied for their sensitivities to heat. In 
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comparing the thermostability of the infective property of the virus 
substrains, it was found that they could again be placed in the same 
heat sensitive and heat resistant groups. However the infective property 
was not inactivated at 56°C at the same rate as the hemagglutinating 
property. The infective property of the GB-S substrain was found to be 
the most heat sensitive of the group. The GB-R substrain was likewise 
the most heat sensitive of the heat resistant group. The 608 atypical-R 
substrain had the most heat resistant infective property of any of the 
substrains studied. 
All of the infectivity heat inactivation curves were bi-phasic in 
nature, typical of those reported for other animal viruses. The curve 
for the 608 atypical-R substrain was less bi-phasic in character than 
the other strains. This had been true in the chicken embryo studies 
with the original substrain. 
The preliminary studies of the hemolysin activity indicated that 
the virus concentration was too low in the tissue culture fluids to give 
satisfactory readings. Therefore, virus infected allantoic fluids with 
higher titers were used to determine the thermostability of the 
hemolysin. The hemolytic property of all substrains was found to be 
much more heat labile than the hemagglutinating property at 56°C, and 
could not be satisfactorily compared at this temperature. However, at 
52°C hemolysin inactivations were of the order of magnitude that meas­
urable comparisons could be made among the virus substrains. The virus 
substrains were found to be either heat sensitive or heat resistant with 
the same thermostability pattern being evident for the hemolytic property 
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that was observed for the hemagglutinating and infective properties. 
The hemolysin of 608 atypical-R substrain demonstrated the greatest 
resistance to heat. 
The most important findings to emerge from the three groups of 
experiments were the distinct parallelisms observed between the data 
obtained for the three properties studied. These findings, borne out in 
detail by the data presented, suggest a structural interpretation of the 
sensitivity and/or resistance to the stress of heat of Newcastle disease 
virus properties. 
The parallel behavior of the resistant and sensitive groups with 
reference to the effects of heat strongly suggests a related mechanism 
of inactivation of hemagglutinin, hemolysin and infectivity. This 
mechanism could act either directly on each property or indirectly by 
the destruction of some related component of the virus. 
Gamma radiation studies were undertaken to establish the relative 
volumes of the components studied with respect to heat sensitivity. 
Definitive data were obtained only for the infective property. Infec­
tivity inactivation curves were exponential in nature and exhibited 
similar slopes for both heat sensitive and resistant substrains, The 
similarity of the slopes indicated that the radiation sensitive volumes, 
i.e., the volume occupied by the infective structure(s), were similar 
for all of the virus substrains. The fact that the infectivity of the 
various substrains tested was equally sensitive to gamma radiation but 
could be placed into two distinct groups with regard to heat sensitivity 
means that the component(s) of the virus which are affected by heat 
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differs between the resistant and sensitive substrains. 
Virus particles which survived the effects of higher doses of gamma 
radiation were screened for variants by neutralization with antiserum 
followed by observation of plaque characteristics and heat sensitivity 
of hemagglutinin and infectivity. The fact that only one variant was 
detected indicates either that induced variation occurs infrequently 
or that the test systems used were not sufficiently sensitive or the 
appropriate ones were not employed. There was no evidence whether the 
variant observed was induced by irradiation or occurred spontaneously. 
The GB-R (isolate after heat) substrain which was obtained from a 
plaque surviving the heat stress may have evolved from a heterogeneous 
population, from a natural variation or from the stress of heat. 
Comparative studies of the frequency of variation between stressed and 
non-stressed populations of virus would be necessary to establish this 
point. 
The two variants observed are of interest because their heat 
inactivation curves differ from those of their respective parents. They 
closely resembled the 608 atypical-R which exhibited a curve which is 
very similar to that of a first order inactivation rate. The heat 
sensitive component(s) of these three strains must be different from 
that of the other strains which exhibited bi-phasic curves. 
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SUMMARY 
1. Newcastle disease virus substrains could be divided into heat 
sensitive and heat resistant groups based on their hemagglutinating, 
infective and hemolytic properties. 
2. Using the radiation data, it was not possible to differentiate 
among the virus substrains. 
3. The radiation sensitive volumes associated with the infective 
property of the virus were similar for all substrains evaluated. The 
infective area was larger than the hemagglutinating and hemolytic sensi­
tive areas because smaller dosages of gamma radiation were needed for 
inactivation of this property. 
4. If the infective sensitive areas of all substrains are equal in 
size, the thermostability data indicate a difference in the component(s) 
which are affected by heat between the resistant and sensitive sub­
strains . 
5. The isolation of two new substrains, different from their 
parent population, further substantiates a difference in the component(s) 
acted upon by heat. 
6. The procedure used for screening isolates after irradiation 
did not prove that changes noted in the isolates were caused by the 
gamma radiation nor that the procedure had any bearing on its isolation. 
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